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A   Introduction 
1. Gels 
Nature has ever since been an inspiration and many engineers and scientists have 
tried to mimic numerous of its features. One of these is self-assembly which is found 
in a variety of natural systems such as proteins,1–3 DNA/RNA,1–4 cell membranes5 
and viruses2,3 but also biomineralization in e.g. bones or mollusc shells.6–8 Another 
example, where the phenomenon of self-assembly occurs is gel formation.  
Gels surround us in our daily life as they are used in manifold fields such as 
agriculture, food and cosmetic industry, pharmaceutical and biomedical applications 
or electronic devices.9–11 
 
Fig. 1 Variety of application fields of gels. 
The term “gel” is not easy to define, as Dorothy Jordon Lloyd recognized in 1926 “the 
gel, is one which is easier to recognize than to define”.12 Graham coined the term 
already in 1864 as being materials that seem to constitute an intermediate state 
between solids and liquids.13 However, over the time many different definitions have 
been made. One of the most comprehensive definitions was presented by Paul Flory 
in 1974.14 According to him, a gel 1) has a permanent continuous structure with 
macroscopic dimensions and 2) in terms of rheology shows a solid like behaviour. In 
general, gels always consist of at least two parts: a solid phase, which is the gelator 
and a liquid phase, which is the solvent, where the latter is the major ingredient. The 
gelator builds up one-dimensional (1D) polymeric structures by either covalent 
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(conventional polymers) or non-covalent forces (supramolecular polymers) which 
then entangle to a three-dimensional (3D) network by physical and/or chemical forces 
and, in this process, includes the solvent molecules mainly through surface tension 
and capillary forces (Fig. 2).15–23 
 
Fig. 2 The formation of supramolecular and conventional polymers. Adapted from Ref. 24 with the 
permission of Royal Society of Chemistry. 
For a better understanding of the hierarchical self-assembly process, the polymeric 
structure of gels can be classified into primary, secondary and tertiary structure (Fig. 
3).21 The primary structure (Å – nm) is defined by the recognition of molecules that 
cause preferably 1D aggregates. The secondary structure (nm - µm) depicts the 
morphology of these aggregates that can be e.g. micelles, vesicles, fibres, ribbons, or 
sheets. Finally, the tertiary structure (µm – mm) comprises interaction of individual 
aggregates and is the final criterion if a stable gel is formed.  
 
Fig. 3 The primary, secondary, and tertiary structure. Reprinted from Ref. 21 with the permission of 
American Chemical Society 
Gels can be classified according to different criteria: 1) medium, 2) source, 
3) constitution or 4) crosslinking (see Fig. 4).17 The medium can vary from organic 
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solvents (organogels), water (hydrogel), or air (aero- or xerogel). Gelators can derive 
from both artificial and natural sources which are mostly polymers (e.g. agarose, 
alginate, chitosan, gelatin, etc.). The constitution describes the nature of the one-
dimensional polymers, which can be macromolecular (covalent linked monomers) or 
supramolecular. Last but not least, gels can be sorted by the type of interaction, 
which is responsible for the three-dimensional network formation which can be again 
covalent (chemical) gel or non-covalent (physical gel).  
 
Fig. 4 Classification of gels. Reprinted from Ref. 17 with the permission of Royal Society of Chemistry. 
 
1.1 Supramolecular Gels 
The first low-molecular-weight gelator (LMWG) was already discovered in the early 
19th century,25 however as the knowledge of aggregation was very poor, it took until 
the 20th century for these type of gelator to gain more interest of the scientific 
community.17 In the early times, supramolecular gelators have been found by 
serendipity, often during a failed crystallization attempt.17 However in the last 20 
years, as the knowledge of aggregation increased, researchers became able to 
design gelators in a rational way, which allows to create material with tailor-made 
properties. As described above, supramolecular gels base on weak, non-covalent 
interactions and typically they are prepared by forcing the gelator into solution by 
heat followed by spontaneous cooling of the isotropic solution to room temperature 
(Fig. 5).17 But gelation can be also induced by various other stimuli, such as 
ultrasonication,26,27 building a pH-gradient28,29 or enzymatically.30 
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Fig. 5 Formation of a supramolecular gel by heating-cooling process. 
During the cooling process, the gelator molecules start to assemble based on forces 
such as hydrogen-bonding, solvophobic forces, π - π stacking, donor-acceptor 
interaction, metal-coordination, etc. to 1D strands which entangle themselves to 
finally build up a 3D network that entrapped the solvent molecules.24,17,22,31–33 
In most of the cases, gelators can only form gels in organic solvents or aqueous 
solutions, although some exceptions exist.34–37 Responsible for this are the different 
types of interactions that cause the self-assembly. The main driving force for the 
formation of organogels are dipolar interactions, hydrogen bonding or metal 
coordination which in sum must overcome the loss of translational and rotational 
freedom (free energy).20,22,24,38 In contrast to this, hydrogelation is dominated mainly 
by solvophobic interactions and therefore control over hydrophobic interactions is 
essential .21,23,39 
Within the last three decades, gels based on LMW-compounds (M < 3000 gmol-1) 
have outnumbered scientific interest of their macromolecular analogues due to a 
variety of reasons:17,21–23,38,39 a) a huge diversity of gelator-structures is accessible by 
standard synthetic methods, b) there are many naturally occurring LMWG which have 
good chances of being biocompatible and biodegradable as their network is solely 
formed by non-covalent forces, which makes them easier biodegradable than 
polymeric gel-systems); c) their thermo-reversible property d) very low minimum 
gelation concentrations are possible and e) their high tolerance towards salts and 
other additives.17,40 All these features make LMW-compound derived gels very 
interesting materials as they can react to a variety of external stimuli and can hence 
be used in a great range of applications. 
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1.2 Application of Gels in Drug Release  
The number of drugs with a low solubility in water with less than 1 g mL-1 represents 
a high percentage.41,42 The disadvantages derived from low solubility in water are 
poor dissolution and membrane permeability, low bioavailability and therefor bad 
efficiency.41–43 Important for an optimal drug action is the presence at the site of 
action, a sufficient concentration for a long enough time period.44,45 In order to 
overcome solubility problems, different strategies have been developed including 
complexation, solid dispersion, micronization, use of co-solvents, colloidal 
particulates (e.g. microemulsions, self-emulsifying drug delivery systems, liposomes, 
niosomes and solid lipid nanoparticles) and nanosizing (nanoemulsions, 
nanosuspensions, nanoparticles, nanocrystals).41–43,46,47 From administration to the 
target site drugs may follow a long route on which they can cause severe side 
effects, especially in case of anti-cancer medicaments.44,45 Therefore parenteral drug 
delivery systems have been studied extensively over the past few decades. In this 
field formulations including for example surgical implants,48 PEGylated 
nanoparticles49 and biodegradable microspheres50 have been developed. 
Unfortunately those formulations suffer from several drawbacks. Polymeric implants 
require a surgical intervention and microspheres are very costly.51  An alternative 
formulation for a huge field of medicaments are gels which can protect their payload 
from enzymes or low stomach pH. Gels have been studied already more than a 
century ago. However, the research interest in this field rocketed around three 
decades ago.52 More than 95% of publications of the last 60 years were published 
after 1989.53 The largest part of these dealt with hydrogels derived from cross-linked 
polymers and there are numerous publications on drug release from gels derived 
from covalent crosslinking. However these carrier systems comprise several 
disadvantages including a costly synthesis, the need of non-biocompatible organic 
solvents, poor mechanics and slow self-healing.51,54 As these gels are formed by a 
self-assembly process based on non-covalent forces they have several advantages 
as they are often injectable and can respond to several bio-medically relevant stimuli 
such as temperature, pH, and the presence of enzymes or ions.55,56  
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B Gels based low molecular weight compounds 
1. Isosteric replacement for tuning self-assembly and incorporating new 
functions into soft supramolecular materials1 
1.1 Introduction  
Bioisosteric replacement is one of the most important tools in medicinal chemistry for 
the rational design of new drugs.57,58 The origins of isosterism can be traced back to 
the early twentieth century to the pioneering work of Langmuir in which he coined this 
concept to define atoms or molecules which possess the same number and/or 
arrangement of electrons.59 Thereafter, Grimm’s hydride displacement law60 and 
Erlenmeyer’s work61 paved the way to the definition of bioisosteres, largely spread by 
Friedman62 and Thornber63 and later broadened by Burger64 as ‘‘compounds or 
groups that possess near-equal molecular shapes and volumes, approximately the 
same distribution of electrons, and which exhibit similar physical properties ...’’. 
Nowadays, bioisosteric replacement of amide bonds represents a key strategy in 
modern research due to its implications in peptide chemistry.65–67 Within this context, 
many promising approaches introducing acyclic esters, thioamides, ureas, 
carbamates, oxadiazoles and diazoles have been successfully applied to improve the 
activity of known drugs or to create new bioactive compounds and materials.58,68 
Among these examples, disubstituted 1,2,3-triazoles have been considered as 
powerful non-classical isosteres of amides as they can mimic either a trans- or a cis- 
configuration of the amide bond depending on the substitution pattern of the triazole 
(1,4- or 1,5-, respectively).69,70 Their planar structure exhibits the ability of H-bonding 
due to the presence of both donor and acceptor groups with similar relative positions. 
Although the distance R1-R2 in trans-amides is about 1 Å shorter than that in 
1,4-disubstituted triazoles, the overall dipolar moment of the latter (about 5.0 D) is 
slightly larger than that of secondary amides (about 3.5–4.0 D). 
                                            
 
1 Adapted from Ref. 37 with permission from The American Society of Chemistry. Gelation 
experiments on C18-Glu and click-Glu were performed by J. Bachl. Gelation experiments on sulfo-Glu 
were performed by J. V. Alegre-Requena apart from stimuli-response tests and Gelation time and Tgel 
vs. concentration experiments, which were conducted by J. Mayr. Synthesis was performed by J. 
Bachl, J. V. Alegre-Requena and J. Mayr. Drug release and antimicrobial experiments were performed 
by J. Mayr. 
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Fig. 6 Main structural features of disubstituted trans-amides and 1,2,3-triazoles for their consideration as 
bioisosteres. Reproduced from Ref. 37 with permission from The Royal Society of Chemistry. 
Moreover, the H-bonding abilities (oxygen lone pair electrons = acceptor; N–H amide 
bond = donor) can be mimicked by the N-2/N-3 lone pairs (acceptor) and the triazole 
C–H bond (donor) (Fig. 6). Calculations in the gas phase have also suggested that 
the lone pair on N-3 may be a better H-bond acceptor and metal coordination center 
than N-2. In addition, the potential β-turn geometry of 1,4-disubstituted triazoles has 
been supported by computational studies.71 A similar analysis can be done between 
cis-amides and 1,5-disubstituted 1,2,3-triazoles. Another important isostere of amides 
is the sulfonamide which is the basis of several groups of drugs. Although there are 
only very few sulfonamides found in nature,72,73 they are a very popular motif in 
pharmacy and agriculture.74 Sulfanilamide, the first sulfonamide was synthesized 
already in 1908 by Gelmo75 followed by the first chemothereutic agent with the brand 
name Prontosil® which was synthesized in 1934 by Mietzsch and Klarer76 and its 
antibacterial efficacy was demonstrated 1935 by Domagk.77 Nowadays sulfonamides 
are not only used as antibiotics but also as diuretics78 and they depict a very 
important class of antiepileptics.79 
Bioisterism proofed to be one of the most important tools in the rational design 
of new drug molecules but we aimed to use it for the development of new gel 
materials. N-stearoyl-L-glutamic acid (C18-Glu) is an amphiphilic compound that has 
been reported to self-assemble into nanofibers in chloroform and nanodisc-like 
structures in 1 : 1 mixed EtOH– water.36 We envisioned that this molecule could also 
undergo self-assembly in many other solvents at suitable concentrations. In addition, 
it provided us with a unique opportunity to assess the transplantation of the isosteric 
replacement paradigm from medicinal chemistry to soft materials.  
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1.2 Results and Discussion  
1.2.1 Gelation properties  
Our group presented in 2014 the replacement of the amide moiety in C18-Glu by a 
1,4-disubstituted 1,2,3-triazole unit, in which the total number of C atoms has formally 
been kept intact. This new compound, click-Glu, was readily synthesized by the 
copper(I)-catalysed azide–alkyne cycloaddition, also known as click reaction.80  
 
Fig. 7 Gelators C18-Glu and click-Glu derived from L-glutamic. 
The gelation ability of C18-Glu and click-Glu was systematically investigated by 
applying a heating–cooling cycle in water and several organic solvents (including 
non-polar, polar protic and polar aprotic solvents). Materials that did not exhibit 
gravitational flow upon turning the vial upside-down were preliminary classified as 
stable gels. No visible changes were observed in model examples upon one year of 
aging, and their gel nature was further confirmed by dynamic rheological 
measurements. Eleven different gels could be obtained with both gelators in 
oxygenated, hydrocarbon (including aromatic and aliphatic) and halogenated 
solvents. Despite the fact that many solvents could be gelled by either C18-Glu or 
click-Glu, the critical gelation concentration (CGC), thermal stability and gelation 
kinetics were different in each case. Click-Glu generally exhibited about 25–55% 
lower CGC values than C18-Glu when polar protic and polar aprotic solvents were 
used (e.g., water, MeOH, glycerol, and MeCN). On the other hand, an opposite 
behavior (around 10–75% higher CGC) was usually observed in non-polar solvents 
(e.g., Et2O, DCM, n-hexane, and toluene). Although most gels were obtained within 
minutes regardless of the gelator structure, the gelation kinetics was found to be 
significantly slower in polar solvents. Independent of the nature of the solvent or the 
gelator, all gels exhibited full thermo-reversibility with gel-to-sol transition 
temperatures (Tgel) in the range of about 40–70 °C as indicated by DSC among other 
techniques. Remarkably, some Tgel values exceeded the boiling points of the 
corresponding solvents. Similar to the trends observed for CGC-values, materials 
Isosteric replacement for tuning self-assembly and incorporating new functions into 
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derived from click-Glu generally exhibited, at comparable concentrations, higher Tgel 
values in polar solvents than those obtained from C18-Glu, which were superior in 
non-polar solvents.  
Electron microscopy imaging was used in order to gain visual insight into the 
morphologies of model gels prepared in water and CHCl3, respectively. 
 
Fig. 8 FESEM images of xerogels A) C18-Glu in water (25 g L-1); B) C18-Glu in CHCl3 (100 g L-1); C) click-
Glu in water (25 g L-1); D) click-Glu in CHCl3 (100 g L-1). 
In good agreement with previous observations,36 FESEM images of the xerogels 
based on C18-Glu in a polar-protic environment revealed the formation of nano-
almond-like structures, whereas layered lamellar assemblies were observed in 
CHCl3. A practically opposite behavior was observed for materials based on the 
isosteric click-Glu. Thus, wrinkled lamellar structures were observed in water, 
whereas almond crunch-like structures were revealed in CHCl3. In general, dense 
fibrillar networks of high aspect ratios were also observed by TEM imaging. When 
click-Glu was used as the gelator, the density of the fibrillary bundles was much 
higher than observed in the case of C18-Glu. 
As the isosteric replacement of the amide function in N-stearoyl L-glutamic 
acid by a 1,4-disubstituted 1,2,3-triazole could be successfully transmitted to the 
tuning of soft materials, we decided to investigate another isostere of an amide 
function which is the sulfonamide. This sulfo-Glu gelator was synthesized via 
substitution of 1-octadecyne sulfonyl chloride by a double tert-butyl protected 
L-glutamic acid and subsequent deprotection. The new compound was tested for its 
gelation ability of the same solvents as described above. 
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Fig. 9 Structure of sulfonamide based gelator sulfo-Glu derived from isosteric replacement. 
In general sulfo-Glu was found to show lower CGCs than the other two gelators in 
non-polar halogenated and aromatic solvents (e.g. DCM, CHCl3, xylene, benzene, 
and toluene) as well as in the polar, aprotic solvents glycerol and MeCN. In contrast 
to click-Glu and C18-Glu, it was able to gel AcOEt, chlorobenzene and benzonitrile. 
However, sulfo-Glu revealed the highest CGC for water and polar protic solvents 
such as MeOH, EtOH, iPrOH. Additionally DMSO, Et2O and n-hexane could not be 
gelled in contrast to click-Glu and C18-Glu which could gel these solvents. 
In the following the influence of gelator concentration on Tgel and gelation time 
was investigated for gels in water and CHCl3 derived from  C18-Glu and click-Glu 
(see Ref. 37 Fig S9) as well for hydrogels derived from sulfo-Glu (Fig. 10). As 
expected, Tgel increased with the increasing gelator concentration regardless of the 
solvent or the gelator, which is in agreement with the gradual formation of denser 
packed supramolecular networks. 
   
Fig. 10 A) Evolution of Tgel with increasing gelator concentration. B) Gelation kinetics of sulfo-Glu. 
For each gelator obvious plateau regions were reached at around 100 g L-1 indicating 
the thermal stability cannot be increased infinitely. The time necessary to form stable 
gels drops extremely with increasing concentration which again indicates a denser 
packaging.  
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Additionally the stimuli response behavior of gels derived from C18-Glu, click-Glu 
and sulfo-Glu was investigated.  
 
Fig. 11 Multistimuli response of a gel derived from sulfo-Glu in water (38 g L-1). 
Generally all gel-materials showed full thermo-reversible behaviour, regardless of 
gelator and nature of the solvent, without any remarkable changes in Tgel-values 
even after several cycles of heating and cooling. Irreversible gel-to-sol phase 
transitions could be observed by mechanical agitation and addition of certain 
chemical substances. Gel-materials were dissolved in the presence of NaOH and 
basic buffered solutions (borate buffer pH = 9.2) while being stable towards neutral 
and acidic conditions. Only click-Glu dissolved slowly upon addition of phosphate 
buffer saline (PBS; pH = 7.4) were C18-Glu and sulfo-Glu remained stable. Treat-
ment with several organic solvents led to multifacted results. While C18-Glu and 
click-Glu were stable against addition of most organic solvents, sulfo-Glu 
underwent phase transition in the presence of EtOAc and n-hexane. Response 
towards other organic solvents (i.e. MeOH, acetone and DCM), as well as to metal-
ions (i.e., Ag+, Cu2+ and Fe3+), halides (TBAF), could not be observed regardless of 
the gelator. In general the response towards external stimuli was quite fast being in a 
range between 30−240 min resulting in complete dissolution or collapse of the gel 
phases.  
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1.2.2 Drug release experiments 
Hydrogels prepared from C18-Glu and click-Glu were for the first time evaluated as 
carriers for tuning the kinetics of drug release. Vancomycin, a useful glycopeptidic 
antibiotic for the treatment of infections mostly caused by Gram-positive bacteria, 
was selected in the first instance as hydrophilic model drug.81 Stable hydrogels 
towards a PBS buffer could be obtained using a gelator concentration of 60 g L-1.  
 
Fig. 12 Left: Release profile of vancomycin in PBS from hydrogels based on click-Glu, C18-Glu and co-
assembled click-Glu:C18-Glu (9:1, w/w). Right: Chemical structure of vancomycin. 
Thus, we used these conditions for preliminary studies of the release kinetics of 
entrapped vancomycin (initial drug concentration in the gel phase = 1.38 x 10-3 M). 
Up to 90% drug release was observed within 13 days in the case of click-Glu, 
whereas C18-Glu showed much slower kinetics (around 56% within the same period). 
In general, release kinetics obeyed a first-order integrated rate law reasonably well 
(kobs [C18-Glu] = 1.5 ± 0.2 x 10-2 h-1; kobs [click-Glu] = 4.3 ± 0.3 x 10-2 h-1). These 
results can be associated with different diffusion properties of the drug through 
hydrogels with diverse nano-morphologies, which are ultimately governed by the 
isosteric gelator structure (obviously, the interaction patterns between solvent–
gelator, gelator–gelator and gelator/fibril-drug molecules play a key role in such a 
complex scenario). As expected, a faster release rate was also observed upon 
decreasing the gelator concentration due to the decrease of the crosslink density of 
the network (Fig. 13A) Remarkably, the complementary structure of the isosteric 
gelators allowed the preparation of stable hydrogels via co-assembly of both gelators 
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at different ratios, offering an alternative tuning option for fine-tuning the drug release 
(Fig. 12).  
 
Fig. 13 A) Effect of the gelator concentration on the release of vancomycin from hydrogels made of click-
Glu and C18-Glu. B) Release of vancomycin from a hydrogel prepared using click-Glu:C18-Glu (1:1, w/w). 
However, the change in the kinetics upon co-assembly was not proportional to the 
molar ratio of the gelator (Fig. 13B) suggesting the formation of complex interpene-
trated networks and release kinetics.  
Not only vancomycin was used as model drug in this study. Also, the release of 
methotrexate hydrate, which is a non-water-soluble anti-cancer agent, was investi-
gated (initial drug concentration in the gel phase = 0.66 x 10-3 M). Gels were 
prepared for this purpose in a stock solution of methotrexate in water/EtOH 1:1 
mixture with C18-Glu and click-Glu. In this case, a gelator concentration of 50 g L-1 
was sufficient to form stable gels in contrast to 60 g L-1 for vancomycin release, which 
is eventually due to the presence of EtOH. However, this is surprisingly, since C18-
Glu did not show the ability to gel pure EtOH. The stability of gels derived from both 
gelators towards addition of PBS turned out to be similar which is in good agreement 
with the great similarity in the release profiles (kobs [C18-Glu] = 2.9 x 10-2 h-1; kobs 
[click-Glu] = 3.3 x 10-2 h-1) of methotrexate from C18-Glu and click-Glu derived gels 
(Fig. 14). Also in the water /EtOH 1:1 mixture a co-assembly of both gelators at 
different ratio was possible. However, again the change in the kinetics upon co-
assembly was not proportional to the molar ratio of the gelator. 
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Fig. 14  Left: Release profile of methotrexate· water in PBS from hydrogels based on click-Glu, C18-Glu 
and co-assemblies of both gelators at different click-Glu:C18-Glu (w/w) ratios. Right: Chemical structure 
of methotrexate·H2O.  
In order to compare the influence of drug hydrophilicity on their release rate, 
preliminary release tests with flutamide and campthotecin, which are anti-cancer 
agents, as well were performed (Fig. 15A and B). The three anti-cancer drugs exhibit 
a molecular weight in the same range but differ in their hydrophilicity (flutamide: logP 
= 3.35 82, camptothecin: logP = 1.74 83, methotrexate: logP = -1.85 83) were 
methotrexate inherits the greatest hydrophilicity and flutamide the greatest 
hydrophobicity. 
  
 
Fig. 15 Release profile of methotrexate·H2O (■,●), camptothecin (■,●) and flutamide (■,●) in PBS from 
hydrogels based on A) C18-Glu and B) click-Glu. C) Chemical structures of flutamide and camptothecin. 
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A clear relation between hydrophilicity and diffusion of the drugs into the surrounding 
release medium was found. This can be explained by the environmental conditions in 
the gel, which are more hydrophobic in comparison to the release buffer. Therefore, 
hydrophobic molecules tend to be more retained in the gel medium which comprises 
the favorable environment. More hydrophilic molecules experience a higher repulsion 
by the gel fibers and a higher attraction by the release medium which leads to a 
faster diffusion into the release medium. 
Finally, also a hydrogel derived from sulfo-Glu was used as a drug carrier for 
vancomycin. Again the drug release followed a first-order integrated rate law (kobs 
[sulfo-Glu] = 1.3 ± 0.1 x 10-2 h-1). Within 13 days around 58% of the initial drug 
amount was released into the surrounding medium whereat the release profile 
showed a remarkable similarity to that from C18-Glu derived hydrogel (kobs [C18-Glu] 
= 1.5 ± 0.2x 10-2 h-1; 56% release in 13 days).  
 
Fig. 16 Release profile of vancomycin in a PBS buffer from hydrogels based on click-Glu, C18-Glu and 
sulfo-Glu. 
1.2.3 Antimicrobial studies 
The antimicrobial activities of the hydrogels with and without vancomycin against the 
Gram-positive bacteria Staphylococcus aureus were evaluated using the Kirby–
Bauer test (Fig. 17, left).  
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Fig. 17 The zone of inhibition test against Staphylococcus aureus. Left) for vancomycin containing 
hydrogels derived from C18-Glu and click-Glu and their corresponding controls right) for release medium 
(on filter paper) after 24 h of vancomycin release from hydrogels. 
Large inhibition zones (21.5 mm and 18 mm for drug loaded click-Glu and C18-Glu, 
respectively) were observed. The results were in good agreement with the faster 
release kinetics of click-Glu hydrogels vs. C18-Glu. No inhibition zones were evident 
with control gel samples. Maintenance of antimicrobial activity of the released drug 
was also confirmed (Fig. 17, right). 
 
Fig. 18 The zone of inhibition test against Staphylococcus aureus Left) for vancomycin containing 
hydrogels derived from sulfo-Glu and their corresponding controls right) for release medium (on filter 
paper) after 24 h of vancomycin release from hydrogels. 
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Also sulfo-Glu derived hydrogels were tested in the Kirby-Bauer test (Fig. 18). Large 
inhibition zones (Ø = 22.5 ± 0.5 mm) were formed around the hydrogel samples 
containing the drug, whereas the bacteria grew almost to the edge of the pure 
hydrogels. Even though the conditions for the zone of inhibition test were the same 
as for click-Glu and C18-Glu the sizes of the inhibition zones cannot be compared 
since the test was not performed on the same agar plate. Testing the buffer medium 
of the drug release experiment after 24 h showed that the antimicrobial activity 
maintained (zone Ø = 14.5 ± 0.5 mm). A positive control (aq. vancomycin solution 
2 g L-1, zone Ø = 20 mm) and a negative control (pure PBS buffer) illustrates, in good 
agreement with the drug release experiment, that within the first 24 h only parts of the 
drug diffused from the gel. 
1.3 Experimental Part 
1.3.1 Synthesis of glutamic acid derived gelators 
Synthesis of N-stearoyl-L-glutamic acid C18-Glu 
 
To a stirred solution of L-glutamic acid diethyl ester hydrochloride (1.72 g, 7.2 mmol) 
and NEt3 (3.0 mL, 21.5 mmol) in dry methylene chloride (150 mL) at 0 °C, a solution 
of stearoyl chloride (2.47 g, 8.2 mmol) in dry methylene chloride (20 mL) was added 
slowly over a period of 1h. The mixture was allowed to warm to RT and stirred for 
additional 3 h, after which time water (50 mL) was added. The organic layer was 
separated, washed with water (4 × 50 mL), dried over Na2SO4, filtered and the 
solvent was removed under reduced pressure. The obtained residue was dissolved in 
a 1:1 mixture of MeOH/water (150 mL) and KOH (1.18 g, 21.6 mmol) was added. The 
obtained suspension was stirred at RT for 18 h. MeOH was removed under reduced 
pressure and the aqueous phase was acidified with 2 M HCl to pH = 2. The formed 
precipitate was filtered off, thoroughly washed with water, dried and recrystallized 
from acetone affording the title compound as white solid. 
Yield: 1.23 g (36%); C23H43NO5 (413.60); 
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1H NMR (300 MHz, DMSO-d6) δ (ppm) 8.03 (d, 1H), 4.21–4.14 (m, 1H), 2.26 (t, 2H), 
2.09 (t, 2H), 2.00–1.88 (m, 1H), 1.80–1.67 (m, 1H), 1.49–1.41 (m, 2H), 1.23 (s, 28H), 
0.85 (t, 3H) 
 
Synthesis of 1H-imidazole-1-sulfonyl azide 
 
Sodium azide (7.5 g, 115 mmol) was suspended in dry MeCN (100 mL) followed by 
cooling this mixture to 0 °C, then thionyl chloride (8.1 mL, 100 mmol) was added 
dropwise over a period of 30 min. After stirring at room temperature for 20 h 
imidazole (13.0 g, 190 mmol) was added in portions and the slurry was stirred at 
room temperature for further 3 h. Subsequently EtOAc (200 mL) was added and the 
mixture was washed with water (3 x 100 mL) and sat. NaHCO3 (3 x 100 mL). The 
organic layer was dried over Na2SO4, filtered and cooled to 0 °C. To this solution 
acetyl chloride (10.7 mL, 150 mmol) was added dropwise over a period of 30 min. 
The slurry was allowed to chill at 0 °C for 1.5 h while precipitation occurred which 
was then filtered and washed with ice cold EtOAc (25 mL) and dried in vacuum to 
give the product as pure white crystalline solid. 
Yield: 11.0 g (52%), C3H3N5O2S·HCl (209.61 g mol-1) 
1H NMR (300 MHz, D2O) δ (ppm) 9.24 – 9.19 (m, 1H); 7.87 – 7.86 (m, 1H); 7.46 – 
7.44 (m, 1H) 
 
Synthesis of (S)-2-azidopentanedioic acid 
 
1H-Imidazole-1-sulfonyl azide hydrochloride (6.23 g, 36 mmol), was added to a 
suspension of L-glutamic acid (4.41  g, 30 mmol), anhydrous potassium carbonate 
(15.34 g, 111 mmol) and copper(II) sulfate pentahydrate (75 mg, 0.30 mmol) in 
methanol (75 mL). The reaction mixture was stirred overnight at room temperature. 
Then, the solvent was removed and the resulting residue was diluted with water 
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(40 mL), acidified with conc. HCl to give pH 2 and extracted with EtOAc (3 × 100 mL). 
The combined organic layers were dried over Na2SO4, filtered and concentrated. The 
resulting residue was purified by column chromatography (eluent: EtOAc) affording 
the desired product as colourless oil.  
C5H7N3O4 (173.13 g mol-1) 
For safety reasons the solvent was not evaporated completely so no yield was 
determined.  
1H NMR (300 MHz, DMSO-d6) δ (ppm) 12.75 (brs, 2H), 4.11 (dd, 1H), 2.39–2.22 (m, 
2H), 2.05–1.98 (m, 1H), 1.88–1.73 (m, 1H) 
 
Synthesis of (S)-2-(5-hexadecyl-1H-1,2,3-triazol-1-yl)pentanedioic acid click-Glu 
 
To a stirred solution of octadec-1-yne (1.20 g, 4.80 mmol) and (S)-2-azidopen-
tanedioic acid (1.25 g, 4.80 mmol) in a 1:2 (v/v) mixture of DMSO/ water (5 mL) at RT 
CuSO4⋅5H2O (120 mg, 0.48 mmol) and sodium ascorbate (380 mg, 1.92 mmol) were 
added. Due to a clear increase of viscosity after a short period of time, the total 
solvent volume was further increased to 10 mL. After stirring for 72 h, the solvent 
mixture was removed by lyophilization. The obtained residue was redissolved in a 1:1 
(v/v) mixture of EtOAc/THF (50 mL) and washed with brine containing 0.1 M 
EDTA⋅Na2 (2 × 50 mL), brine (2 × 25 mL) and water (3 × 25 mL) in order to remove 
most of organic and inorganic impurities. The organic layer was dried over Na2SO4, 
filtered and concentrated under reduced pressure. The obtained residue was 
recrystallized from acetone affording the title compound as a white solid. 
Yield: 1.01 g (50%), C23H41N3O4 (423.60g mol-1) 
1H NMR (300 MHz, DMSO-d6) δ (ppm) 7.95 (s, 1H), 5.35 (dd, 1H), 2.60 (t, 2H), 2.46–
2.37 (m, 1H), 2.35–2.22 (m, 1H), 2.17–1.96 (m, 2H), 1.58 (t, 2H), 1.23 (s, 26H), 0.85 
(t, 3H) 
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Synthesis of (octadecylsulfonyl)-L-glutamic acid sulfo-Glu 
 
1-octadecyne sulfonyl chloride (1.44 g, 4.1 mmol) was dissolved in dry DCM (40 mL) 
under N2-atmosphere at 0 °C. NEt3 (1.71 mL, 12.3 mmol) and L-Glutamic acid di-tert-
butyl ester·HCl (1.21 g, 4.1 mmol) were added. The reaction mixture was stirred at 
0 °C for 1 h and subsequently for 3 days at room temperature. The solvent was 
evaporated and the resulting residue was purified by column chromatography (eluent 
hexanes/EtOAc 5:1 to 1:5). The intermediate was redissolved in DCM (18 mL) and 
TFA (3 mL) and was stirred at room temperature for 18 h. The solvent was 
evaporated and crude product was washed with ice cold DCM (20 mL) to give the 
desired product as a white solid. 
Yield: 1.06 g (56%); C23H45NO6S (463.67);  
1H NMR (300 MHz, DMSO-d6) δ (ppm) 7.57 (m, 1H); 3.83 (m, 1H); 2.94 (m, 2H); 2.33 
(m, 2H); 1.92 (m, 1H); 1.67 (m, 3H); 1.23 (s, 30H); 0.85 (t, 3H) 
1.3.2 Gelation time and Tgel vs. concentration 
Gelator and milli-Q water (500 µL) were placed in screw capped vials (final 
concentrations 38, 50, 60, 100, 150 and 200 g L-1). The samples were heated until 
turbid solutions were formed. The time that was necessary for gel formation was 
measured by turning the vials upside down and the point where no flow occurred was 
considered as being the gelation time. After resting for 19 h, the samples were 
heated in a custom-made heating block at a rate of about 2 °C / 5 min. Melting points 
were measured by inverse flow method.  
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1.3.3 Stimuli response test 
A weighted amount of the corresponding gelator and milli-Q water (500 µL) were 
placed in a screw capped vial (final concentrations: C18-Glu 25 g L-1, click-Glu 
17 g L-1 and sulfo-Glu 38 g L-1, respectively). The samples were tempered in a 
custom made heating block at 100 °C for 1 h whereat homogeneous, turbid solutions 
were formed. Subsequently the samples were allowed to cool slowly to room 
temperature. After 19 h stable gels were obtained which were overlaid with each 
500 µl of different solvents or solutions (0.1 M). The samples were stored at room 
temperature and observed for 24 h.  
1.3.4 Drug release 
A weighted amount of the corresponding gelator (50 – 60 mg), and 1 mL of a drug 
stock solution (vancomycin: 2 g L-1 in water, methotrexate hydrate: 0.3 g L-1 in 
water/EtOH 1:1; camptothecin: 0.1 g L-1 in water/EtOH 9:1; flutamide: 0.8 g L-1 in 
water/EtOH 9:1) were placed in a screw-capped glass vial and gently heated until all 
solid materials were completely dissolved. The obtained isotropic solution was 
allowed to cool down to RT resulting in gel formation with a physically incorporated 
drug. 
Obtained gel materials were overlaid with phosphate buffered saline (PBS, 1 mL, 
pH = 7.4) 16 h after their formation, which was considered as the starting point for the 
experiments. At selected points of time aliquots (100 μL) were removed and diluted 
with PBS to 1 mL. Then fresh PBS (100 μL) was added over the gel to maintain 
infinite sink conditions. Drug concentration in the aliquots was determined during the 
experiments using UV-spectroscopy after proper calibration using the maximum 
absorbance of drugs in aqueous media (vancomycin: 280 nm; methotrexate hydrate 
303 nm; camptothecin: 371 nm; flutamide: 303 nm). Samples were centrifuged (EBA 
12 Hettich Zentrifugen) at 4000 rpm for 5 min before measurements. It was verified 
that degraded gel materials exhibited a minimum absorbance in the region of drug 
detection. 
1.3.5 Antimicrobial studies 
The Zone of Inhibition Test, also called Kirby-Bauer Test, is used clinically to 
qualitatively measure antibiotic resistance and industrially to test the ability of 
specimens to inhibit microbial growth. 
Isosteric replacement for tuning self-assembly and incorporating new functions into 
soft supramolecular materials  
 
22 
 
Preparation of agar plates: A solution of 1% peptone, 0.5% yeast, 0.2% glucose and 
1.5% of agar-agar (w/v) in milli-Q water was autoclaved at 120 °C for 20 min and 
then shaken. After cooling down to 95 °C, a Petri dish (8.5 cm diameter) was filled to 
half of the volume (about 25 mL). The dishes were shaken circularly on the bench to 
bring air bubbles to the edge. After cooling to room temperature, the plates were 
placed upside down to avoid condensed water to drop on the medium and stored in 
the refrigerator at 2-8 °C. 
Hydrogels preparation: An aqueous vancomycin solution (1 mL from a 2 M solution) 
was added to a screw-capped vial containing either C18-Glu, click-Glu or sulfo-Glu 
(60 mg). The mixture was heated until complete dissolution of the material, 
transferred to a 2 mL syringe with cut cap and rested over night to obtain the 
corresponding stable hydrogels. 
Antimicrobial tests with hydrogel pieces: S. aureus was seeded out evenly with a 
cotton bud on agar medium. Cylindrical gel pieces of approximately 4 mm length and 
9 mm diameter (0.25 mL) were placed on the bacteria plates. The plates were stored 
at 37 °C for 17 h. 
Release of vancomycin from the hydrogels: An aqueous vancomycin solution (1 mL 
from a 2 M solution) was added to a screw-capped vial containing either C18-Glu, 
click-Glu or sulfo-Glu (60 mg). The mixture was heated until complete dissolution of 
the material and rested over night to obtain the corresponding hydrogels. The 
loaded-hydrogels were overlaid with PBS buffer (1 mL) and rested for additional 24 h. 
Antimicrobial tests with drug release supernatants: S. aureus was seeded out evenly 
with a cotton bud on agar medium. Three samples of filter papers were soaked 
separately in 20 μL of (a) supernatant obtained from the drug release experiment, (b) 
pure PBS and (c) aqueous vancomycin solution (2 M). The specimens were placed 
on the plates and stored at 37 °C for 17 h. 
1.4 Conclusions  
In conclusion, the isosteric replacement paradigm from medicinal chemistry can be 
successfully applied to the synthesis of novel soft functional materials. As a proof-of-
concept, isosteric gelators C18-Glu, click-Glu and sulfo-Glu afforded the preparation 
of a variety of physical hydrogels and organogels with different thermal, mechanical, 
morphological and diffusional properties. In general, click-Glu revealed superior 
features with respect to the CGC, Tgel and mechanical stabilities in polar protic 
solvents, whereas sulfo-Glu exhibited improved properties in non-polar solvents and 
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C18-Glu showed in average values between those of click-Glu and sulfo-Glu. 
Additionally the three isosteres proofed to be applicable for the in vitro delivery of 
drugs with different sizes and hydrophilicities. A sustained release over several days 
up to two weeks could be achieved, where diffusion from click-Glu derived hydrogels 
was faster than from C18-Glu and sulfo-Glu, which exhibited similar release profiles. 
Moreover, the co-assembly of C18-Glu and click-Glu was successfully applied for 
fine-tuning the release of the antibiotic vancomycin and the anti-cancer agent 
methotrexate. The antibiotic activity of vancomycin loaded hydrogels against the 
Gram-positive Staphylococcus aureus, as well as maintenance of efficacy of the 
released drug was also confirmed. Overall, these results open up many exciting 
opportunities for the development of new functional materials with unique properties 
for different applications beyond the field of gels. 
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2. Release of camptothecin, oxytetracycline and mitoxantrone from glycyrrhizic 
acid derived water/ethanol gels into several buffered solutions  
2.1 Introduction  
Glycyrrhizic acid (GA) or glycyrrhizin is a natural occurring saponin, which can be 
extracted from the licorice (liquorice) root (Glycyrrhiza glabra) in the form of its 
potassium, calcium and magnesium salts. It is the ingredient which is mainly 
responsible for the sweet taste of this root. The chemical structure consists of a 
lipophilic pentacyclic triterpenoid and a hydrophilic part which are two β (1→2) linked 
glucuronic acid units (Fig. 19) Due to this amphiphilic structure it is able to form 
micelles in water and water/alcoholic solutions. Its ability to form stable hydrogels 
was already described in 1879 by Habermann.84 
 
Fig. 19 Structure of Glycyrrhizic acid 
X-ray crystallography has shown that GA can self-assemble into a supramolecular 
interdigitated network, with alternating hydrophilic and hydrophobic areas.85,86 The 
diglucuronic acid units build up hydrophilic platforms via H-bonding (Fig. 20) while 
the hydrophobic areas, deriving from terpenoid structures, exhibit channels which can 
be filled with solvent or guest molecules. Remarkably chemical differences between 
GA and its mono- and dibasic salts practically have no impact on the supramolecular 
organization. This isomorphism is due to a specific structure of hydrophilic bilayers 
assembled from zigzag chains of neutral, mono-anionic, or di-anionic diglucuronic 
acid units. Counter ions like ammonium, potassium, or cesium were found to be able 
to replace hydrogen-bonded water molecules in the hydrophilic sugar platform. 
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Fig. 20 Self-assembly of glycyrrhizic acid. A) Ball and stick and B) space filling representation. Reprinted 
from Ref. 86 with permission from American Chemical Society. 
The applications of GA are manifold, e.g. as emulsifier and sweetener in food 
industry. Apart from that, the Glycyrrhiza glabra has been used as medical plant for 
more than 100 years. Glycyrrhizic acid has many pharmaceutical application it has 
been found to have anti-hepatotoxic,87,88 anti-ulcerogenic,89 anti-allergenic90 and anti-
inflammatory activities91 as well as inhibitory activities in the replication of several 
DNA and RNA viruses in vitro.92 Indeed GA has been also used as an adjuvant for 
drug delivery due to its ability to solubilize poorly water soluble drugs which was first 
described in 1963.93 The first time glycyrrhizin was used as a drug carrier itself, was 
presented by Segal et. al in 1986, where the authors entrapped several bioactive 
compounds in hydrogels derived from GA for the treatment of mucosal lesions due to 
herpes.94  
2.2 Results and Discussion 
2.2.1 Drug Release 
Glycyrrhizic acid ammonium salt is also a good hydrogelator with excellent biocom-
patibility whose hydrogels additionally are able to tolerate up to 25 wt% ethanol. 
Therefore, it is an interesting candidate for the physical entrapment and subsequent 
release of hydrophilic as well as hydrophobic drug molecules. For the purpose of 
studying the drug release from glycyrrhizic acid ammonium salt derived gels, in the 
first instance, two drug molecules with different hydrophilicity, namely camptothecin 
(CAMP) (logP = 1.7483) and oxytetracycline hydrochloride (OXY) (logP = -0.9095) 
were used as model drugs. Stable hydrogels containing the drug molecules could be 
A B 
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obtained using a gelator concentration of 20 g L-1. After 16 h of equilibration time the 
samples were overlaid with several buffered solutions. In the first instance the 
release of camptothecin and oxytetracycline into acetate buffer pH 4.5, phosphate 
buffered saline (PBS) pH 7.4 and borate buffer pH 8.3 was investigated (Fig. 21). 
Clean release curves were achieved which could be fitted reasonably well by 
Weibull’s equation (see Fig. 27). In good agreement with results described in chapter 
B, the more hydrophilic OXY was released considerably faster and in a clearly 
greater amount (around 4 fold) than the less water soluble camptothecin. As 
mentioned before, due to the more hydrophobic environment of the gel material in 
comparison to the release buffer the more hydrophobic drug experiences a greater 
retention than a more hydrophilic compound. Hydrophobic molecules experience a 
greater retention from the gel medium in contrast to more hydrophilic molecules 
which are more repelled by the gel fibers and have a higher attraction to the release 
medium and hence diffuse faster.  
 
Fig. 21 Left: Release profile of oxytetracycline·HCl and camptothecin from hydrogels based on glycyrrhizic 
acid ammonium salt into several buffered solutions at different pH values. pH 4.5: acetate buffer, pH 7.4: 
phosphate buffered saline and pH 8.3: borate buffer. Error bars are calculated as standard deviation from 
at least two independent experiments. Right: Chemical structures of oxytetracycline·HCl and 
camptothecin.  
We expected a clear trend in the release rate depending on the pH of the release 
medium. However, no such trend was observable. The order of release rate of oxy 
into the buffer solutions was PBS > acetate buffer ≥ borate buffer whereas for camp it 
was PBS ≥ borate buffer > acetate buffer. Interestingly the two drugs did not show 
the same buffer dependency in their release behavior. One factor could be the 
diffusion of buffer salts into the gel medium which can cause different responses like 
shrinkage, swelling or erosion. But also the attraction between drug and release 
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medium might play an important role. As these results did not provide us with clear 
answers we decided to run quick tests with three further buffer solutions for the 
release of camp, namely 2-(N-morpholino)ethanesulfonic acid (MES) buffer at pH 3.7 
and pH 5.5 as well as carbonate buffer at pH 9.2.  
 
Fig. 22 Release profile of camp from hydrogels based on glycyrrhizic acid ammonium salt into several 
buffered solutions at different pH values. pH 3.7: MES, pH 4.5: acetate buffer, pH 5.5: MES, pH 7.4: 
phosphate buffered saline, pH 8.3: borate buffer and pH 9,2 carbonate buffer. 
However, still no explicit influence of environmental pH on release rate could be 
drawn (Fig. 22). Nonetheless some interesting results were found. The release of 
camptothecin into carbonate buffer at pH 9.2 was extremely rapid and finished at a 
value of around 50% after only 4 hours which is clearly due to the rapid dissolution of 
the gel material. The next fastest release rates were exhibited with PBS pH 7.4 and 
borate buffer pH 8.3 which are close to neutral pH. The diffusion into those buffers 
reached values of around 25% and 21%, respectively after 3 days. Interestingly, 
release profiles into MES buffers at two different pH values did not show any 
difference, which indicates, the nature of the buffer system might have a stronger 
influence than pH. The release into acetate buffer was the slowest with a level of 
around 13%. It seems that an acidic environment stabilizes the gel material and 
hence leads to a slower release of embedded drugs than more basic environments.  
In order to check the long term delivery of drugs, the release of camptothecin into 
PBS was monitored for 13 days where the release still did not reach a plateau level, 
which gives good expectances that glycyrrhizic acid ammonium salt derived gels can 
act as a depot with long term delivery of more than two weeks of camptothecin. 
Unfortunately such test could not be performed with OXY as this drug degraded over 
time in an aqueous environment, indicated by an orange discoloration of the 
originally clear gel as well as a shift of the absorbance maximum after around 48 h 
(Fig. 23).   
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Fig. 23 Left: Discoloration of oxy containing gel after around 1 week. Right: shift of absorbance maximum 
of oxy over time. 
As the stability of OXY caused problems, we decided to look for a new hydrophilic 
model drug. Mitoxantrone hydrate (MITOX) which is a good water soluble (logP = 
-2.9 96) anti-cancer drug, with an absorption maximum of 661 nm was chosen. Again 
the release into those buffer solutions mentioned above was performed, where 
carbonate buffer was omitted as it caused a rapid dissolution of the gel.  
 
Fig. 24 Left: Release profile of MITOX from hydrogels based on glycyrrhizic acid ammonium salt into 
several buffered solutions at different pH values. pH 3.7: MES, pH 5.5: MES, pH 7.4: phosphate buffered 
saline and pH 8.3: borate buffer. Right: Chemical structure of MITOX. 
Surprisingly no signal of MITOX release into acetate buffer, even after 9 days, could 
be observed (see also Fig. 26). In good agreement with camptothecin release, also 
the release of MITOX into the two different MES buffers was very similar. However, 
the diffusion into the more acidic MES buffer was slightly faster (~ 6% after 7 days) 
than that into the more basic one (~6% after 9 days). The next faster release was 
found to occur in the presence of borate buffer with reaching a maximum of around 
8% within 24 h. In agreement with CAMP and OXY, the diffusion into PBS buffer was 
the fastest (excluded carbonate buffer). In general MITOX release curves did not 
follow any typical diffusion models – in contrast to CAMP and OXY - which suggests 
a coexistence of diffusion and erosion phenomena. This, the generally very slow 
diffusion of MITOX as well as the nonappearance of release in the presence of 
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acetate buffer indicates a strong interaction between MITOX and the gelator 
molecules and presumably a destabilization of the gel fibres. The latter would need to 
be proven by rheological measurements. 
2.2.2 Response to buffer solutions 
One reason for the non-concrete dependence of drug release rate on the environ-
mental pH could be the varying reactions of the gel material towards the different 
buffer systems (see Fig. 25). A complete gel-sol transition was observed upon 
addition of highly basic (pH 9.2) carbonate within around 8 h. This process was also 
observed in still basic (pH 8.3) borate buffer and neutral (pH 7.4) PBS, whereas 
degradation was much slower. Around half of the gel material dissolved within 3 
days. Additionally in case of PBS the, at first transparent, gel turned translucent over 
time which indicates a formation of particles bigger than the wavelength of visible 
light (350–750 nm). In general the presence of an acidic environment did not affect 
the gel stability as no degradation was observed. However, MES buffer which is the 
only buffer system which is not based on inorganic but on organic salts, led to a 
swelling of the gel material accompanied by a phase separation. This may be inferred 
that MES diffuses into the gel and thereby introduce additional solvent.  
 
Fig. 25 Response of glycyrrhizic acid ammonium salt derived gels in water/EtOH 9:1 (20 g L-1) with 
physically entrapped CAMP (0.1 g L-1). 
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2.3 Experimental Part 
Glycyrrhizic acid ammonium salt from glycyrrhiza root (licorice) and oxytetracycline 
hydrochloride were purchased from Sigma Aldrich. (S)-(+)-camptothecin was 
purchased from TCI. 
A weighted amount of the corresponding gelator (20 mg), and 1 mL of a drug stock 
solution (MITOX: 0.6 g L-1 in water; OXY: 0.08 g L-1 in water; CAMP: 0.1 g L-1 in 
water/EtOH 9:1) were placed in a screw-capped glass vial and gently heated until all 
solid materials were completely dissolved. The obtained isotropic solution was 
allowed to cool down to RT resulting in the formation of a transparent gel with 
physically incorporated drug. 
Obtained gel materials were overlaid with 1 mL buffer solution (MES pH = 3.7; 
acetat4e buffer pH = 4.5; MES pH = 5.5; PBS pH = 7.4; borate buffer pH = 8.3 or 
carbonate buffer pH = 9.2) 16 h after their formation, which was considered as the 
starting point for the experiments. At selected points of time aliquots (100 μL) were 
removed and diluted with the corresponding buffer to 1 mL. Then fresh buffer 
(100 μL) was added over the gel to maintain infinite sink conditions. Drug 
concentration in the aliquots was determined during the experiments using UV-
spectroscopy after proper calibration using the maximum absorbance of drugs in 
aqueous media (MITOX hydrate: 661 nm; OXY: 357 nm; CAMP: 371 nm). It was 
verified that degraded gel materials exhibited a minimum absorbance in the region of 
drug detection. 
2.4 Conclusions 
Glycyrrhizic acid ammonium salt, a natural product derived from the licorice root, was 
used to gel water and water/ethanol solutions. Three different bioactive agents, 
namely camptothecin, oxytetracycline hydrochloride and mitoxantrone hydrate were 
selected as model drugs for the physical entrapment into these gels and the 
subsequent release into several buffered solutions namely MES pH 3.7, acetate pH 
4.5, MES pH 5.5, PBS pH 7.4, borate pH 8.3 and carbonate buffer pH 9.2. In good 
agreement with previous results, comparison between the relatively hydrophobic 
CAMP and the more hydrophilic OXY revealed much faster release rates for the latter 
over the prior as the gel material depicts a more hydrophobic environment than the 
surrounding release medium and therefore exhibits a greater retention for more 
hydrophobic drugs. Interestingly the even more hydrophilic MITOX showed in 
average the slowest release rates. This and the observation, that MITOX loaded gels 
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suffer from a greater erosion suggests a strong interaction between this drug and the 
gelator molecule which can cause a destabilization of the gel fibers. These results 
demonstrate clearly the difficulty of predicting the release behavior from matrix type 
drug formulations.  
In addition, the dependence of drug delivery on the environmental pH was aimed 
to investigate. In general it was observed that acidic environment led to a slower 
release of embedded drugs than more basic environments as GA ammonium salt 
derived gels were sensitive towards basic solutions. However, the nature of the buffer 
system also had a strong impact on release rates. This exposes the limitations of in 
vitro drug delivery experiments. Nevertheless those kind of investigations play an 
important role in gaining preliminary insights into the potential application of gel 
materials as drug carriers before in vivo experiments can be considered.  
2.5 Additional Graphics 
 
 
Fig. 26 Photographs of GA ammonium salt derived hydrogels with physically entrapped MITOX, overlaid 
with different buffer solutions. 
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Fig. 27  Log(-ln) – log plot showing the monomial relationship between drug release and time. Release of 
CAMP into A) acetate pH 3.7 B) PBS pH 7.4 C) borate pH 8.3 and release of OXY into D) acetate pH 3.7 
E) PBS pH 7.4 F) borate pH 8.3.  
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3. Improvement of gelation properties of a formamidine based gelator by 
ultrasonication2 
3.1 Introduction  
During the last decades formamidines received great attention. They have been 
described to be easily synthesized and have a high potential for biological and 
pharmacological applications.97–103 Formamidines such as chlordimeform104–106 and 
amitraz106,107 have been used as insecticides already since the late 1960s in a large 
industrial scale, however later have been proven to inherit potentially carcinogenic 
activity. Another field where formamidines are popular is in the design of new drug 
molecules as they have been found to increase bioactivity in comparison to parent 
drugs.108 Also in the field of organo-metallics, formamidines are applied as 
complexing agents for metals in catalysis as they offer high structural variety and 
diversity of binding modes.109–112 But so far they have not been used in materials 
sciences. However in 2014 when Díaz and Finn attempted to find new synthetic 
approaches towards multi-substituted formamidines, their amphiphilic compounds 
turned out to be able to gel protic organic solvents.98 
Supramolecular gels with viscoelastic properties are stimuli-responsive 
materials which were intensively studied during the last decades as they found to 
have applications in a great variety of fields such as food, agriculture, catalysis, 
sensing, cosmetics and biomedicine.9–11 According to Flory a gel has a permanent 
continuous structure with macroscopic dimensions and in terms of rheology shows a 
solid-like behavior.14 Gels can be e.g. divided into organogels and hydrogels 
according to the nature of the solvent. Other classifications are chemical113 or 
physical114 gels depending on the types of interactions (covalent or non-covalent, 
respectively) which are responsible for the network formation. 
In the case of low-molecular-weight gelators (LMWG), the gel formation is based on 
the self-assembly of LMWG molecules into one-dimensional strands and the 
entanglement of the latter, which can be typically achieved by cooling hot isotropic 
solutions to room temperature.114,115 
Besides the classical heating-cooling protocol for gel-formation, some compounds 
are also known to form gels upon application of ultrasound.116–118  This is remarkable 
                                            
 
2 In this chapter gelation experiments were performed by J. Bachl. Remaining experiments were 
performed by J. Mayr. 
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as previously it was assumed that ultrasonic waves would disrupt self-assembly in 
solution.119 Here we report a novel amphiphilic gelator molecule bearing a 
formamidine unit, which shows enhanced gelation properties upon ultrasonication 
treatment in comparison to a standard heating-cooling protocol. 
3.2 Results and discussion  
A new formamidine based, amphiphilic gelator compound (FAG) (Fig. 28), consisting 
of a long carbon chain (C16) and acetyl L-phenyl alanine connected via a formamidine 
function was synthesized in four steps. 
 
Fig. 28 Formamidine based, amphiphilic gelator compound.  
Briefly, first protection of C-terminus of L-phenylalanine as methyl ester, followed by 
protection of N-terminus by an acetate. Next step was the transformation of the 
methyl ester into a hydrazine ester. Last but not least hexadecyl-dimethylform-
imidamide was formed, where subsequently dimethylamine was substituted by the 
acetyl-L-phenylalanine hydrazine ester to give the final gelator molecule.  
The gelation ability of the FAG was investigated for 30 organic solvents of 
different nature (apolar, polar aprotic or polar protic) by applying a classical heating-
cooling cycle. Materials that did not exhibit gravitational flow according to the “stable-
to-inversion” method were preliminarily classified as gels and their solid-like 
appearance was further confirmed using dynamic rheological measurements. The 
FAG was not able to form gels with DMF, THF and chlorinated solvents like DCM, 
CHCl3 or 1,2-dichloroethane as its solubility in these solvents was too high, while 
gelation of glycerine failed due to insolubility. Partial gels at maximum concentrations 
of 200 g L-1 have been formed in alcoholic solvents like MeOH, EtOH, i-PrOH, 2-
butanol, 1-hexanol. Nineteen other solvents, including two room temperature ionic 
liquids, aromatic and several oil-based solvents, were able to produce stable gels in a 
concentration range varying from about 15-150 g L-1 for most samples, which opens 
the door for potential applications in removal of oil spills and fabrication of conducting 
materials. During investigations concerning other approaches towards the formation 
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of stable gels different to the classical heating-cooling cycle, it was found that 
ultrasound-treatment of isotropic solutions of FAG and an appropriate organic solvent 
had a remarkably positive effect. Not only could the range of solvents gelled be 
extended by the 5 alcoholic solvents mentioned above. But also gel properties 
themselves could be enhanced drastically. The critical gelation concentration (CGC) 
could be reduced by at least 23% and up to 82%, gelation kinetics were up to 99% 
faster and thermal stability increased up to 33% (at same gelation concentration). 
Last but not least rheological measurements of gels in MeCN and toluene revealed 
enhanced mechanical stability (with respect to the absolute value of G', the tan δ and 
the maximum % strain at break) of those gels prepared with ultrasound-treatment in 
comparison to the classical heating-cooling cycle. Due to this demonstrative 
superiority of ultrasound-formed gels, this gelation method was used for all further 
experiments. 
In order to study the driving forces for molecular aggregation, temperature-dependent 
1H-NMR spectra of a gel in MeCN-d3 were recorded in a range of 35 to 65 °C in steps 
of 5 °C. Three different regions were selected to show which protons are involved in 
the gelation process. First an N-H signal in the field of 8.08 to 8.00 ppm was picked 
(Fig. 29A), that revealed a small downfield shift of the signal by around 0.027 ppm. 
Another downfield shift could be observed for the phenyl protons (Fig. 29B). In this 
case the shift was much smaller, around 0.008 ppm. The biggest shift was observed 
for the major C-H signal of the long carbon chain with 0.062 ppm (Fig. 29C). 
According to these results H-bonding, π - π-stacking, as well as van-der-Waals 
interactions are responsible for the gelation process, although their impact seems to 
be of varying importance. 
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Fig. 29 A-C) Shift of proton signals in 1H-NMR spectra with rising temperature. A) N-H (8.08 - 8.00 ppm), 
B) phenyl C-H (7.34 - 7.16 ppm and C) C-H from carbon chain (1.34 – 1.24 ppm). D) UV-Vis of FAG in 
MeCN as gel at CGC and in solution. 
In good agreement with the results derived from temperature-dependent 1H-NMR, 
UV-Vis analysis showed a shift of the absorption maximum from 288 nm in solution to 
296 nm in the gel phase (Fig. 29D), suggesting that the aggregation mode of the 
FAG in solution differs from that in the gel phase. 
 
 
Fig. 30 Optical microscope images at 500 x magnification of A) an organogel in MeCN at CGC, B) gel-sol 
transition upon heating and C) a few seconds of cooling. 
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Additionally, thermo-reversible features of gels in MeCN were shown under optical 
microscopes in Fig. 30 at 500 x magnification and Fig. 31A+B at 43.75 x 
magnification and under polarized light. Also the anisotropic behaviour was 
demonstrated under polarized light (Fig. 31C+D). In Fig. 31A+B the ability of 
organogels for turning on/off their birefringence in a temperature-dependent manner 
is depicted. The ability to control the refractive index of soft materials constitutes an 
important property for applications in optical devices. 
 
Fig. 31 Polarized light microscope images (at 43.75 x magnification) of A, C, D) organogel in MeCN at 
CGC and B) solution upon gel-to-sol thermal transition. A, B, D) with and C) without crossed polarizers. 
 
Powder X-ray diffractograms (PXRD) of FAG as powder (as derived from synthesis) 
and xerogels derived from a MeCN organogel and a hydrogel were recorded. 
Interestingly the original powder showed crystalline behavior as seen in the relatively 
sharp reflexes from 2θ = 21 – 42 (see Fig. 32).The reflexes at 2θ = 3 and 6 imply a 
short range order which could derive from early self-assembly processes during 
synthesis/isolation. Xerogel from hydrogel did not show any crystalline behaviour 
anymore. However signals at 2θ = 3 and 6 were still present which implies a 
persistence of the short range order (sharp reflexes derive from NaCl, a left-over of 
the hydrogelation process). Surprisingly these reflexes were not observable in the 
xerogel which was derived from MeCN organogels indicating that crystal growth is 
more likely in hydrogels, rather than in organogels.  
Improvement of gelation properties of a formamidine based gelator by ultrasonication 
38 
 
 
Fig. 32 PXRD of FAG as powder and xerogels derived from MeCN organogel and hydrogel. For a more 
detailed vision see annex. 
Lattice spacing d was calculated according to Bragg’s equation 
𝑑 =
𝑛𝜆
2 𝑠𝑖𝑛𝜃
 
where n is the diffraction order and λ the wavelength of the CuKα1 radiator (1.54 Å). 
 
Table 1 Calculation of lattice spacing in FAG powder and xerogel derived from a FAG hydrogel according 
to Bragg’s equation. 
powder xerogel water 
2θ (°) n d (Å) 2θ (°) n d (Å) 
3.07 1 28.83 3.05 1 28.97 
5.95 2 29.71 6.40 2 27.64 
19.8 1 4.44 21.3 1 4.16 
22.5 1 3.95   
  23.8 1 3.74       
 
 
Unfortunately, an MTT assay of FAG revealed a toxic behaviour of both the gelator 
itself as well as FAG derived hydrogels, which led to an exclusion of biomedical 
applications. 
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3.3 Experimental Part 
3.3.1 Synthesis  
Synthesis of (S)-methyl L-phenylalaninate 
 
(L)-Phenylalanine (5.00 g, 42.0 mmol) was added carefully in portions to a cooled 
solution of thionyl chloride (15.30 mL, 210.0 mmol) in MeOH (50 mL) at 0 °C. After 
stirring for 1 h, the solution was allowed to warm to RT and stirred for additional 18 h. 
The solvent was removed under reduced pressure and the resulting residue was co-
evaporated with MeOH (5 x 30 mL) to give the title compound as white solid without 
need of purification. 
Yield: 6.45 g (99%); C10H13NO2; (179.22) 
1H-NMR (300 MHz, MeOD): δ (ppm) = 7.42 – 7.32 (m, 3H), 7.29 – 7.24 (m, 2H), 4.33 
(dd, 1H), 3.81 (s, 3H), 3.29 – 3.13 (m, 2H). 
 
Synthesis of methyl acetyl-L-phenylalaninate 
 
(S)-methyl L-phenylalaninate (5.00 g, 27.9 mmol) was added in one portion to a 
cooled solution of acetic anhydride (11.0 mL, 116.4 mmol) in pyridine (9.5 mL, 
117.7 mmol) at 0 °C. After stirring for 0.5 h, the solution was allowed to warm to RT 
and stirred for 2 days. After addition of ice-water (50 mL), the aqueous mixture was 
extracted with DCM (4 x 25 mL) and the combined organic layers were washed with 
sat. NH4Cl (3 x 25 mL), 0.1 M HCl (3 x 25 mL) and water (3 x 25 mL). The organic 
layer was dried over Na2SO4, filtered and the solvent removed under reduced 
pressure to give the title compound as light brown solid. 
Yield: 4.62 g (75%); C12H15NO3; (221.26) 
1H-NMR (300 MHz, CDCl3): δ (ppm) = 7.31 – 7.20 (m, 3H), 7.11 – 7.05 (m, 2H), 5.98 
(s, 1H), 4.88 (dt, 1H), 3.71 (s, 3H), 3.18 – 3.03 (m, 2H), 1.97 (s, 3H). 
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Synthesis of (S)-N-(1-hydrazineyl-1-oxo-3-phenylpropan-2-yl)acetamide 
 
To a stirred solution of methyl acetyl-L-phenylalaninate (4.14 g, 18.8 mmol) in MeOH 
(125 mL) was added carefully hydrazine*H2O (2.0 mL, 41.2 mmol) and the mixture 
was stirred at RT for 2 days. The solvent was removed under reduced pressure to 
give the title compound as white solid. 
Yield: 4.06 g (97%); C11H15N3O2 (221.26) 
1H-NMR (300 MHz, MeOD): δ (ppm) = 7.31 – 7.16 (m, 5H), 4.55 (dd, 1H), 3.08 (dd, 
1H), 2.87 (dd, 1H), 1.89 (s, 3H). 
Synthesis of FAG 
A solution of hexadecylamine (1.00 g, 4.1 mmol) and 1,1-dimethoxy-N,N-dimethyl-
methanamine (0.30 mL, 6.2 mmol) was stirred in dry MeCN (100 mL) under 
N2-atmosphere for 5 h at 70 °C until TLC-analysis showed full consumption of the 
amine starting material. The solvent was removed under reduced pressure using a 
rotary evaporator and trace amounts of the acetal were removed by co-evaporation 
with toluene (3 x 20 mL). The resulting residue was redissolved in dry MeCN (60 mL) 
under a N2-atmosphere. At 70 °C (S)-N-(1-hydrazineyl-1-oxo-3-phenylpropan-2-yl) 
acetamide (0.92 g, 4.1 mmol) was added in one portion. After stirring for 18 h at 
70 °C the reaction solution was allowed to cool down to RT resulting in the formation 
of a precipitate, which was filtered off, washed with MeCN (3 x 20 mL) and 
recrystallized from acetone twice to yield the desired product as a white solid. 
Yield: 0.91 g (37%); C28H48N4O2 (472.72) 
1H-NMR (300 MHz, MeOD): δ (ppm) = 7.44 – 6.90 (m, 6H), 4.54 (s, 1H), 3.21 – 3.05 
(m, 3H), 3.02 – 2.80 (m, 1H), 1.91 (s, 3H), 1.88 (s, 1H), 1.51 (s, 2H), 1.29 (s, 28H), 
0.90 (t, 3H). 
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3.3.2 Gel-formation 
Preparation of organogels via a heating-cooling cycle 
A weighted amount of the formamidine-based gelator and an appropriate organic 
solvent (0.5 mL) were placed into a screw-capped glass vial (4 cm length ± 1 cm 
diameter) and gently heated with a heat gun until the solid material was completely 
dissolved. In some cases ultrasonication of the samples before heating could 
facilitate the dissolution of the compound. The resulting isotropic solution was then 
spontaneously cooled down to RT. No control over temperature rate during the 
heating-cooling process was applied. The material was preliminary classified as “gel” 
if it did not exhibit gravitational flow upon turning the vial upside-down at RT. The 
state was further confirmed by rheological measurements. 
Preparation of organogels via ultrasound treatment 
An isotropic solution consisting of the formamidine compound and an appropriate 
solvent obtained by gentle heating was treated with ultrasound while still be warm 
using a VWR™ ultrasonic cleaner (USC200TH, 45 kHz, 120 Watt) keeping a 
constant temperature of 23 ± 2 °C. During sonication stable gels were formed in situ 
during time intervals varying from a few seconds to several minutes, which were 
defined as the time necessary to promote gelation. Sole ultrasound treatment without 
applying heat did not facilitate gelation due to simple solubility issues of formamidine 
based gelator in most organic solvents.  
Preparation of hydrogels 
Hydrogelation of the formamidine compound could be achieved by building a pH 
gradient in aqueous solution. The procedure of formation of hydrogels at optimized 
conditions is given as following: A certain amount of the formamidine (35 mg) is 
placed in a screw-capped glass vial when water (0.4 mL) was added. A minimum 
amount of 1 M HCl (0.05 mL) is added to the mixture in order to dissolve the 
compound by gentle heating. Thereto 1 M NaOH is added in portions of 0.01 mL (in 
total 0.04 mL) during treatment with ultrasound until a translucient gel-material at a 
final concentration of 71 ± 8 g L-1 was formed in situ.  
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3.3.3 Temperature controlled NMR 
A gel of formamidine in MeCN-d3 was prepared at CGC following ultrasonication-
protocol. After chilling overnight at room temperature, 1H-NMR were recorded on a 
400 MHz Bruker Avance spectrometer from 35 to 65 °C in steps of 5 °C. Before each 
measurement the gel was tempered for 20 min.  
3.3.4 UV-Vis 
UV-Vis spectra of a formamidine gel in xylene at CGC and a solution in xylene at 
around 4 g L-1 was recorded on an Ocean Optics, Flame Spectrometer with a DH-
2000-BAL light source. 
3.3.5 Polarized Light 
The birefringence of the gels under polarized light was monitored using a Wild 
Makroskop M420 optical microscope equipped with a Canon Power shot A640 digital 
camera. 
3.3.6 PXRD 
Powder X-ray diffraction (PXRD) patterns were collected on a STOE STADI P 
powder diffractometer (Start Fragment Transmission mode, flat samples, Dectris 
MYTHEN 1k microstrip solid-state detector) with CuKα1 radiation operated at 40 kV 
and 40 mA. Conditions: Start Fragment 0.0151°, time 60 s per step, 2 theta range 2–
90°. 
3.4 Conclusions 
In conclusion the effective gelation of various organic solvents by an amphiphilic 
formamidine-based gelator molecule was described. Interestingly ultrasound 
treatment of isotropic solutions resulted in an enhancement of typical physical 
properties of gel materials in all tested cases. For example, CGC could be reduced 
by at least 23% and up to 82%, gelation kinetics were up to 99% faster and thermal 
stability increased up to 33%. Additionally an enhancement of mechanical stability of 
those gels prepared with ultrasound treatment in comparison to the classical heating-
cooling cycle was shown by rheological measurements of gels in MeCN and toluene. 
Also hydrogels could effectively be prepared by building a pH-gradient in aqueous 
media from acidic to more basic conditions. Temperature dependent 1H-NMR spectra 
depicted that H-bonding, π - π-stacking, as well as van-der-Waals interactions are 
responsible for the gelation process. Also in UV-Vis spectra a shift of absorption 
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maximum revealed a different aggregation of FAG in solution than in the gel-phase. 
Polarized light microscopy revealed the ability of a FAG derived gel in MeCN to turn 
on/off the birefringence in a temperature-dependent manner which is an important 
property for potential applications in optical devices. Interestingly PXRD showed 
crystallinity of FAG powder but only short range order in xerogels derived from a 
hydrogel and signals in xerogels derived from a MeCN organogel, indicating that 
crystal growth is more likely in hydrogels, rather than in organogels. Last but not least 
an MTT assay of FAG was performed revealing a toxic behaviour of both the gelator 
itself as well as FAG derived hydrogels, which leads to an exclusion of biomedical 
applications. 
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C   Ionenes 
1. Antimicrobial and Hemolytic Studies of a Series of Polycations Bearing 
Quaternary Ammonium Moieties: Structural and Topological Effects3 
1.1 Introduction 
Around one fourth of the global deaths annually are caused by infections.120–122 The 
unjustifiable use of antibiotics and disinfectants has caused a huge rise in the 
occurrence of resistant strains.123–126 Only in USA over 2 million people are infected 
with these strains and more than 23000 die yearly for this reason.127 In Europe more 
than 150000 patients are affected by methicillin-resistant Staphylococcus aureus 
(MRSA) infections, which leads to costs of 380 million euros per year.128,129 Hence, 
the demand for new antibiotics to combat resistant strains is currently very high. Low 
molecular weight compounds like antimicrobial peptides have been found to be 
effective against a wide spectrum of bacteria.130,131 However, they often comprise 
disadvantages such as the need for a multistep synthesis or biocidal diffusion, which 
can cause toxicity and may lead to a fast resistance.132,133 An alternative and 
versatile approach is the use of antimicrobial active polymers, whose physical, 
chemical and biological activities can be fine-tuned by simple modifications of the 
corresponding monomers. Among different antimicrobial polymers134–137, ionenes are 
synthetic polycations with quaternary ammonium functions, which are distributed 
along the backbone.138,139 In general, the synthesis of ionenes can be performed by 
a) self-polyaddition of aminoalkyl halides, b) Menshutkin reaction between bis-tertiary 
amines and activated dihalide compounds or c) via cationic functionalization of 
precursor polymers.140,141 In 1935, Domagk reported for the first time the antibiotic 
activity of quaternary ammonium salts (QAS).142 Since then different QAS have been 
extensively investigated as disinfectants.143–147 Recently, Xiao and co-workers have 
reported a comprehensive overview of the synthetic methods and antimicrobial action 
of polymers with quaternary ammonium/phosphonium salts.148 The long review 
demonstrates the high relevance of such materials for the search for new 
antimicrobial compounds. Related to the type of ionenes that we describe in this 
paper, Mathias and coworkers reported bis-quaternary ammonium carboxylate 
                                            
 
3 Reproduced from Ref. 185 with permission from MDPI. Synthesis of ionenes was carried out by J. 
Mayr and J. Bachl. All other experiments were performed by J. Mayr. 
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polymers based on 1,4-diazabicyclo-[2.2.2]-octane (DABCO) with good activities 
against Staphylococcus aureus and Escherichia coli.149 In addition, Melkonian and 
her group functionalized cotton to give an antimicrobial material where DABCO was 
also used to introduce the quaternary ammonium function by attaching different 
aliphatic chains.150 Most of these polymers were active against a range of Gram-
negative and Gram-positive bacteria. 
Herein, we report the antimicrobial properties of different ionene polymers 
based on N,N′-(p-phenylene)dibenzamide and α,ω-tertiary diamines, whose self-
assembly properties have been previously described by us 151 and others 152 . The 
antimicrobial activity against the Gram-negative bacterium Escherichia coli has been 
determined for a library of 13 ionenes with different topologies and diamine linkers 
(Fig. 33). 
 
Fig. 33 A) General structures of ionene polymers used in this study and B) charged diammonium moieties 
with different structures and chain length. The combinations investigated in this work were o-DABCO, o-
C2, o-C3, o-C6, m-DABCO, m-C2, m-C3, m-C4, m-C6, p-DABCO, p-C2, p-C3 and p-C4. Note: o- = ortho-; 
m- = meta-; p- = para-. 
1.2 Results and Discussion 
Ionene polymers were synthesized via a two steps process as previously 
reported.151–153 Briefly, first step involves the amidation of o-, m- and p-phenylene-
diamine with 4-(chloromethyl)benzoyl chloride in the presence of Et3N in DCM to 
afford the corresponding bis-benzamides in good yields (75–98%) upon 
recrystallization. Subsequent copolymerization of the obtained bis-benzamides with 
Antimicrobial and Hemolytic Studies of a Series of Polycations Bearing Quaternary 
Ammonium Moieties: Structural and Topological Effects 
46 
 
the desired α,ω-diamine linker under equimolar conditions in DMF at 80 ºC afforded 
the desired pure polymers (Fig. 33) within 2–6 days in modest yields (43–80%) after 
a simple filtration, washing and drying protocol 151–153 In order to achieve adequate 
solubility and mobility of the polymers for GPC analysis, it was necessary to carry out 
counteranion exchange of chloride by bis(trifluoromethanesulfonyl)amide (TFSA) 
anions using LiTFSA in hot water as previously described.151–153 As expected for 
many step-growth polymers, these ionenes·TFSA are generally characterized by low 
degree of polymerizations (n = 7–34) and high dispersity values (Đ = 2.1–6.5).151–153 
The resulting ionenes were tested for antimicrobial activity and the minimum 
inhibitory concentration (MIC) was investigated in a range of 0.125 to 2 mmol L-1, 
respectively (Fig. 34). The lowest MIC was found for m-C6 and p-C3 with values of 
0.2 mmol L-1 followed by m-C3 and p-C2 with MICs of 0.5 mmol L-1and p-C4 of 
1.2 mmol L-1. Interestingly, compounds containing DABCO instead of linear linkers 
showed quite high MICs (i.e., 1.4, 1.6 and 1.8 mmol L-1, respectively), similarly to o-
C6 and m-C4 that revealed MICs of 2 mmol L-1. Surprisingly, ionenes o-C2 and m-
C2 did not show any antimicrobial activity within the measured range. Overall, these 
results suggested a synergistic role, at least to some extent, between the polymer 
topology and the nature of the tertiary diamine linker. 
 
Fig. 34 Minimum inhibitory concentrations (MIC) of ionene suspensions for inhibition of bacterial growth. 
Each value represents the mean of MIC from at least three replicates with standard deviation (SD) and 
analysis of variances (ANOVA) with (*) Bonferroni comparison or (0) unpaired t-test. * Indicates p < 0.05; 
** indicates p < 0.01; ***/000 indicates p < 0.001. 
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Despite the difficulty to draw correlations between the structural moieties and 
efficiency in bacterial toxicity, DABCO-containing compounds always showed 
comparably high MIC values (1.4–1.8 mmol L-1), only exceeded by o-C6 and m-C4 
within the experimental error. Interestingly, o- and m-ionenes bearing the C2-linker 
did not show any antimicrobial activity (not depicted). This phenomenon could be 
explained by a judicious degree of flexibility in the polymer chain. Moreover, o-
substituted polymers also revealed comparably higher MICs (0.8–2.0 mmol L-1). The 
high tendency of these polymers to form coils, which was described in a previous 
publication 151, could hinder the efficient interaction of these polymers with the cell 
membrane. Ionenes with the C3-linker revealed comparably low or the lowest MICs 
(0.9, 0.5 and 0.2 mmol L-1 for the corresponding o-, m-, and p-topomers, 
respectively). Apparently, a medium sized chain length (C3) of the linker in these 
polymers has the optimal effect on the antimicrobial activity. In contrast, in the case 
of m-topomers, the ionene with the longest chain showed the strongest activity 
(0.2 mmol L-1). It seems evident that a proper balance between flexibility and 
topological features of these polymers is needed for optimal effects. In comparison to 
other antimicrobial polymers, our compounds lie in a good middle field. As 
representative examples, Tew and co-workers described quaternary pyridinium 
functionalized polynorbornenes with MICs ranging from 4–200 µg mL-1 (7.2  10–3 – 
0.40 mmol L-1) 122; Lecomte’s group described a poly(oxepan-2-one) with quaternary 
ammonium with a very high MIC of 12.6 g L-1 (23 mmol L-1) 134 and Mathias and 
coworkers reported bis-quaternary ammonium methacrylate polymers with MICs 
ranging from 62.5 to 250 µg mL-1 (0.095 – 0.40 mmol L-1) 149.  
Since antimicrobial agents should be ideally not harmful to mammalian cells, 
the hemolytic activity of these polymers was also tested at similar concentration as 
for the antimicrobial assay. Thus, the polymer solutions were measured at 2 mmol L-
1, which was the limit for antimicrobial studies, and 1 mmol L-1 for comparison (Fig. 
35). The results showed that these ionenes are not or only slightly hemolytic, judged 
by very low levels of released hemoglobin in most cases. However, release of 
hemoglobin increased with increasing polymer concentration. In general, DABCO-
containing polymers revealed the highest hemoglobin levels, being m-DABCO the 
ionene of this class with the lowest values (15% and 8% for 2 mmol L-1 and 
1 mmol L-1, respectively). About 10% reduction of hemoglobin release was observed 
for m-DABCO compared to o-DABCO and p-DABCO at both concentrations.  
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Fig. 35 Mean values of hemolysis from at least three replicates with SD and ANOVA with Bonferroni 
comparison. For the sake of clarity, only comparisons within one topomeric set (ortho-, meta-, para-) at 
2 mmol L-1 are shown in this plot. All DABCO-containing compounds showed higher hemolysis (***, 
omitted for clarity) in comparison to their set members. * Indicates p < 0.05; *** indicates p < 0.001. 
The remaining polymers showed hemoglobin release ranging between 13% for p-C3 
2 mmol L-1 and 1% for m-C3 at both concentrations. In general, the length of the 
linear linker within the same series of topomers showed an irregular effect on the 
hemolytic properties. Thus, the lowest hemolysis was observed for p-and o-topomers 
with a C2-linker (5% and 4%, respectively) at 2 mmol L-1, whereas the same the C4-
linker provided the lowest hemoglobin release for the m-series (0.25%). On the other 
hand, the topology of the polymers seemed to be a more important factor at higher 
concentration (2 mmol L-1) within the series bearing the same linker, albeit again 
without a regular trend. Thus, m-topomers displayed lower hemoglobin release than 
the corresponding o- and p-topomers with a C2-linker (4% vs 1% and 5%, 
respectively). The same was found for C3-, C4- and DABCO-linkers, whereas no 
significant differences were found for the series based on C6-linkers. With respect to 
the concentration effect, the most pronounced differences between the two 
concentrations were found for the p-series. For comparison, hemolysis obtained with 
other polycations such as poly(diallyl-dimethyl-ammonium chloride) and poly(vinyl 
pyridinium bromide) were found to be 2.6% and 9.4%, respectively,154 within the 
same range of concentration as we used for this investigation.  
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Fig. 36 Static contact angle for films prepared with the different ionenes as described in the Experimental 
Section. Reliable measurements were not obtained for samples prepared with o-DABCO (too hydrophilic), 
p-C4 (too hydrophilic) and o-C6 (inhomogeneous film). 
In contrast to other polycations,155 contact angle measurements of films prepared 
with the different ionenes revealed no obvious correlations between the antimicrobial 
or hemolytic activity and the surface wettability of the polymers (Fig. 36). Although 
DABCO-containing polymers displayed in general higher MIC, hemolytic activity and 
higher hydrophilic character (i.e., contact angle < 30º) compared to the ionenes 
bearing linear linkers, other significant correlations among the different linkers and 
topological features of the polymers were not found. 
1.3 Experimental Section  
1.3.1 Materials 
Starting materials for polymer synthesis were purchased from Sigma Aldrich or TCI. 
TGYE-medium ingredients were from Becton, Dickinson and Company. Müller-
Hinton-Broth was purchased from Merck. Hemolysis was measured on a sunrise 
tecan microplate reader.  
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1.3.2 Synthesis of Ionenes 
Synthesis of N,N'-(1,2-phenylene)bis(4-(chloromethyl)benzamide) ortho-monomer 
 
To a stirred solution of 1,2-diaminobenzene (1.62 g, 15.0 mmol) and Et3N (5.23 mL, 
37.5 mmol) in DCM (70 mL) at 0 ºC a solution of 4-(chloromethyl) benzoyl chloride 
(5.67 g, 30.0 mmol) in DCM (40 mL) was added dropwise via a pressure-
compensated addition funnel. The reaction mixture was allowed to warm to RT and 
stirred for 0.5 h, until TLC analysis showed full conversion of the starting materials. 
The solvent was removed in vacuum and the resulting yellowish solid was used 
without further purification   
Yield: 5.95 g (96%); Rf = 0.9 (DCM: MeOH 10:1); C22H18Cl2N2O2 (413.30) 
1H NMR (300 MHz, DMSO) δ (ppm) = 10.10 (s, 2H), 7.98 (d, 4H), 7.68 (d, 2H), 7.62 
(d, 4H), 7.32 (d, 2H), 4.83 (s, 4H). 
Synthesis of N,N'-(1,3-phenylene)bis(4-(chloromethyl)benzamide) meta-monomer 
 
 
Synthesis was performed as described for ortho-monomer. However solvent was 
not evaporated but mixture was stored overnight at 4 °C and resulting precipitate was 
filtered off, washed with ice cold DCM and dried to afford the product as white solid. 
Yield: 5.44 g (88%); Rf = 0.8 (DCM: MeOH 10:1); C22H18Cl2N2O2 (413.30) 
1H NMR (300 MHz, DMSO) δ (ppm) = 10.36 (s, 2H), 8.38 (t, 1H), 7.98 (d, 4H), 7.62 
(d, 4H), 7.52 (d, 2H), 7.42 (m, 1H), 4.88 (s, 4H). 
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Synthesis of N,N'-(1,4-phenylene)bis(4-(chloromethyl)benzamide) para-monomer 
 
Synthesis was performed as described for ortho-monomer. The resulting precipitate 
was filtered off, washed with ice cold DCM and dried to afford the product was white 
solid.  
Yield: 6.13 g (99%); Rf = 0.7 (DCM: MeOH 10:1); C22H18Cl2N2O2 (413.30) 
1H NMR (300 MHz, DMSO) δ (ppm) = 10.28 (s, 2H), 7.97 (d, 4H), 7.76 (s, 4H), 7.59 
(d, 4H), 4.85 (s, 4H). 
Representative preparation of polymers; o-DABCO 
 
To a stirred solution of ortho-monomer (0.82 g, 2.00 mmol) in DMF (15 mL) at 80 °C 
1,4-diazabicyclo[2.2.2]octane (DABCO) (0.22 g, 2.00 mmol) was added in one 
portion. The reaction mixture was stirred at 80 °C for 2 days, until TLC analysis 
showed full conversion of the starting materials. The mixture was cooled down to RT, 
stored at 4 °C overnight, filtered, washed subsequently with DMF, MeCN and DCM, 
and the final product was dried in vacuo. 
General reaction duration: 2-6 days. 
General yields: 70-95% 
1H NMR see annex. 
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1.3.3 Antimicrobial assay 
TGYE-medium (30 mL) was inoculated with one colony of Escherichia coli, incubated 
at 37 °C while orbital shaking at 150 rpm overnight. From this suspension a 1:100 
dilution was prepared in Müller-Hinton-Broth (MHB) and 50 µL of this were added to 
1 mL of solutions/dispersions of the polymers at different concentrations in MHB (i.e., 
2, 1, 0.5 0.25 and 0.125 mM from serial dilution starting from 4 mM polymer in 
sodium chloride 9 g/L solution. The bacteria were incubated at 37 °C for 18 h. After 
this time 50 µL of sample were spread on TGYE agar plates, which were incubated 
at 37 °C for 22 h and bacterial growth was optically evaluated. MIC was determined 
as the lowest concentration of polymers at which no visible growth was observed. 
1.3.4 Hemolysis testing 
Blood from a healthy human volunteer was drawn into K2-EDTA coated vacutainer 
tubes and stored at 4 °C for 1 h. The blood was centrifuged at 1000 g for 10 min. The 
erythrocytes were washed with 2 mL PBS buffer and centrifuged again (3 times). The 
erythrocytes were resuspended in PBS buffer to give a 5% (v/v) suspension. 
Solutions/dispersions of polymers in sodium chloride 9 g/L solution (60 µL), 
erythrocyte suspensions (60 µL) and PBS buffer (60 µL) were mixed. As positive 
hemolysis control Triton-X100 1% (v/v) (60 µL) and as negative control PBS buffer 
(60 µL) was used. Samples were incubated at 37 °C and orbital shaking at 150 rpm 
for 2 h followed by centrifugation at 1000 g for 5 min. Sample solution (60 µL) and 
PBS buffer (60 µL) were filled into a 96 well plate and absorbance was measured at 
540 nm. Hemolysis was calculated by following equation. 
ℎ𝑒𝑚𝑜𝑙𝑦𝑠𝑖𝑠 =  (
𝑆𝑃𝐵𝑆 − 𝑆𝑃𝑜𝑙𝑦
𝑆𝑇𝑋 − 𝑆𝑃𝑜𝑙𝑦
) ∙ 100% 
where SPBS is the value corresponding to the negative control, STX is the value 
corresponding to the positive control and Spoly is the value corresponding to the 
polymer sample.  
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1.3.5 Contact angle measurements 
Polymer solutions/suspensions were prepared at a concentration of 50 g/L in DMSO/ 
water (1:1, v/v). Menzel cover slips (18  18 mm) were washed with acetone and 
ethanol before usage. Samples (50 µL) were spread on the glass plates to cover as 
much as possible of the surface. The plates were left on air for 3 days to dry. The 
measurements were performed with a Dataphysics Contact Angle System OCA by 
dropping 3 µL on the surface and images were analyzed with the software SCA 20. 
1.4 Conclusions 
In summary, ionene polymers with different topologies derived from a disubstituted 
aromatic monomeric core and α,ω-ditertiary amines were prepared via step-growth 
polymerization. The polymers showed antimicrobial activity against the Gram-
negative bacterium Escherichia coli, with MIC values affected by both the topology of 
the polymer and the nature of the diamine linker. In general, all ionenes containing 
DABCO (1.4–1.8 mmol L-1), as well as ortho-compounds with other linkers (0.8 –
2.0 mmol L-1), showed higher MICs. In contrast, medium chain length (C3) showed 
best or comparably low MICs (0.9, 0.5 and 0.2 mmol L-1 for ortho-, meta- and para-, 
respectively). In this assay, all DABCO-containing polymers showed a relatively high 
hemoglobin release (15–31%) whereas meta-compounds in general provided the 
lowest hemolysis (0–15%). In conclusion, meta-compounds with a flexible linker 
provided the best properties from both assays, and represent the most promising 
candidates for potential antimicrobial applications. 
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2. Transfection of Antisense Oligonucleotides Mediated by Cationic Vesicles    
Based on Non-Ionic Surfactant and Polycations Bearing Quaternary 
Ammonium Moieties4 
2.1 Introduction 
The last decades have been witness of a growing interest in the use of synthetic 
oligonucleotides for the inhibition of gene expression156 as an alternative to classical 
small-molecule drugs to treat diseases. Examples for such oligonucleotides are 
antisense oligonucleotides, short interfering RNAs (siRNAs),157 aptamers,158 
DNA/RNAzymes and antisense-induced exon-skipping.159,160 In order to achieve the 
desired inhibition some obstacles must be solved. The first problem to solve is the 
high sensitivity of oligonucleotides towards degradation by serum nucleases. This 
has been partially solved by the use of chemical modifications of the oligonucleotides 
at the sugar ring and/or at the phosphate back bone in order to increase their 
biostability.161,162 Cellular uptake of polyanionic oligonucleotides across the 
negatively charged cell membrane constitutes another problem. Although it has been 
shown that viral vectors are highly efficient for the transfection of plasmid DNA, there 
are still concerns about immunogenicity or recombination of oncogenes. Several 
alternatives for viral transfection methods have been developed including 
formulations, as a very fast and simple method.163 
In 1987, Felgner and co-workers reported the first transfection experiment. 
They used the cationic lipid N-[1-(2,3-dioleyloxy)propyl]-N,N,N-trimethylammonium 
(DOTMA) for carrying out an efficient DNA-transfection protocol.164 Since this, a huge 
variety of cationic lipids for formulation of oligonucleotides have been described.165,166 
Even though they comprise promising tools for nucleic acid delivery there are several 
aspects to be considered. Cationic lipids have the tendency to interact with plasma 
proteins, which has a detrimental effect on transfection efficiency.167 In addition, high 
positive net charge of the formulation can cause toxicity. Therefore a demand for new 
formulations is still present. One alternative to cationic lipids is the use of 
formulations based on cationic polymers and non-ionic surfactant agents to fine-tune 
the net charge. Cationic polymers are able to interact with DNA and RNA molecules 
with high efficiency and thus generate complexes with a relatively small size. This 
                                            
 
4 Reproduced from Ref. 218 with permission from MDPI. J. Mayr and J. Bachl synthesized the 
polymers. J. Mayr and S. Grijalvo performed the rest of the experiments. R. Pons designed the SAXS 
experiments. 
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particularity makes cationic polymers as useful non-viral carriers for improving gene 
transfection efficiency.167,168 Although poly(ethylenimine) (PEI) and poly(L-lysine) 
(PLL) are the most well-known and used polymers for gene therapy, the synthesis 
and efficiency of novel cationic polymers to interact with nucleic acids in order to 
mediate cellular uptake have been recently reviewed.168,169  
Ionenes are synthetic polycations with quaternary ammonium functions, which are 
distributed along the backbone.138,139 In general, they can be synthesized by (a) self-
polyaddition of aminoalkyl halides, (b) Menshutkin reaction between bis-tertiary 
amines and activated dihalide compounds or (c) via cationic functionalization of 
precursor polymers.140,170 Inspired by our results which described the self-assembly 
properties of 1,4-diazabicyclo[2.2.2]octane (DABCO) derived ionene151 as well as dye 
uptake153 and phase-transfer catalysis,171 we decided to take advantage of the 
positively charged diammonium moieties present in ionene structures as cationic 
monomers to favor the electrostatic interaction process with nucleic acids.172–175 In 
this work we have prepared surfactant-ionene formulations with a series of ionenes 
made of N,N′-(o-phenylene) dibenzamide (1) and α,ω-tertiary diamines (Fig. 37) with 
the aim to further study the DNA complexation  in terms of zeta potential, small-angle 
X-ray scattering (SAXS) and effect of transfection efficiency potency in antisense 
technology156 by studying the ability of the polyplexes depending on the linker length 
and flexibility of the polymers to inhibit Renilla luciferase gene. As mentioned above 
the use of a non-ionic surfactant in the formulation (Tween 80) aims to avoid 
interactions with plasma proteins167 and cell toxicity observed for cationic lipids. Our 
findings showed cationic ionene polymers formulated with a non-ionic surfactant were 
not toxic and were able to deliver antisense oligonucleotides into cells and thereby 
inhibited luciferase expression with promising efficiencies. These results open new 
insights on the design of novel ionene-based non-viral carriers for nucleic acids. 
 
Fig. 37 Structures of ionene polymers used in this study with charged diammonium moieties with different 
structures and chain length. 
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2.2 Results and Discussion 
2.2.1 Size and Zeta-Potential Measurements 
Cationic vesicles containing the respective ionene polymer and polysorbate 80 as a 
non-ionic surfactant agent, were prepared by the thin-film hydration method in 20 mM 
HEPES (pH 7.4) buffer solution. A fixed amount of an antisense oligonucleotide (0.5 
µM, Luc) was used to obtain a series of polyplexes at several N/P ratios that ranged 
from 0.05 to 6. Finally, the surface charge was measured in order to determine the 
overall charge of the preformed ionene polyplexes in solution. 
As depicted in Fig. 38, a transition from negative to positive values was clearly 
observed when the ionene concentration of the prepared cationic vesicle formula-
tions was increased. This change suggested the evidence of electrostatic interactions 
among negatively charged oligonucleotides and positively charged vesicles, which 
led to the formation of the expected ionene-based polyplexes. Interestingly, we 
noticed that this transition was different depending on the formulation used. Thus, in 
case of DABCO-ionene the formulations reached a positive net charge at N/P ratios 
≥ 1.5; whereas for C2- and C6-ionene was around ≥ 0.5, 1 and 4, respectively. All 
formulations reached a plateau when compensated the surface charge density by 
increasing the number of cationic polymer chains in the three systems (N/P ratio of 2, 
4 and 6). 
 
Fig. 38 Zeta potential of polyplexes at several N/P charge ratios derived from ionene polymers, antisense 
oligonucleotide and polysorbate 80. (A) DABCO-ionene, (B) C2-ionene, (C) C6-ionene. 
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Surprisingly, we observed similar trends in the behaviour of the systems when ionene 
formulations were added at lower N/P ratios. In particular, an initial decrease in the 
charge of the complexes was detected upon the addition of the cationic polymers, 
followed by a charge increase as described before. This initial decrease in the charge 
ratio was also observed and described with other family of cationic polymers like 
DNA-PEI complexes.176 Similarly, the presence of initial amounts of cationic polymers 
in the three systems may result in varying the degree of folding of DNA molecules by 
decreasing the amount of free DNA and therefore leading to an increase in the 
concentration of the negative charge. This effect was primarily observed when the 
first ionene-based polymers were added to these three systems. 
2.2.2 SAXS Measurements 
To further investigate the structural information of our preformed ionene polyplexes, 
solutions of DNA salmon testes in 20 mM HEPES (pH 7.4) were put in contact with 
two representative ionene-based vesicle formulations (C2- and C6-ionene). The 
expected viscous complexes were formed, separated from the excess solution and 
washed with deionized water. The first attempts to visualize the scattered X-ray 
intensities were unsuccessful because the scattering signal was too weak for both 
complexes (data not shown). It is well known that DNA can be compacted by cationic 
surfactants forming lipoplexes, which in turn can co-precipitate at high concentrations 
forming gels having strong mechanical properties. When a drop of a concentrated 
DNA solution is placed in contact with a concentrated cationic surfactant solution, 
macroscopic films can be obtained that surround the droplet. Interestingly, these films 
are quite consistent as they can be cut and opened. Furthermore, films can be also 
dried and rehydrated preserving their main structural properties as observed by 
SAXS.177 Thus, to get better resolution and enhance the signal spectra the resultant 
two complexes were further concentrated by evaporation. This process significantly 
showed the presence of one peak, which could be assigned to the pre-formed DNA 
complexes with C2- and C6-ionene, respectively. 
As illustrated in Fig. 39, scattered X-ray intensities of the two ionene complexes 
showed the presence of single peaks in which their position did not differ too much 
among each other (q = 2.402 and 2.306 nm-1 for polyplexes based on C2- and C6-
ionene, respectively). 
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Fig. 39 A) Scattered X-ray intensity as a function of scattering vector q at 25 °C. The complex for 
C2-ionene (green) and C6-ionene (blue) are shown together. The scattering pattern produced by the 
Salmon testes DNA (black) is also included as a control. The expected positions of second and third 
reflexions for hexagonal packing are shown for C6-ionene as arrows. B) Representative DLS measurement 
of polyplex made of C6:Luc oligonucleotide. C) Representative cryo-scanning electron microscopy image 
of polyplexes based on C6-ionene. 
Disappointingly, we were not able to detect the presence of a second and third peak 
throughout the spectra, which might confirm a hexagonal packing of our pre-formed 
complexes. Additionally, the scattering pattern for DNA salmon testes without forming 
complexes was also included in the spectra for reference as a control. However, if we 
assume hexagonal symmetry as observed in lipoplexes,178 the distance calculated 
between the centres of cylinders is 3.0 nm for C2-ionene and 3.1 nm for C6-ionene. 
By comparing these results with DNA complexes made using other kinds of 
surfactant agents, we see that both ionene complexes are much more compact (for 
example, the observed distances between cylinders was 4.2 ± 4.7 nm in the case of 
several lipo-amino acid derivatives whereas the distance for CTAB and MTAB were 
6.5 and 5.68 nm, respectively).179 If we tentatively compare these distances with the 
dimensions of a DNA double helix (diameter 2.2 ± 2.6 nm),180 it seems that the 
structure of ionene-based complex might pack in a different way. Taking into 
consideration that DNA chains can form hexagonal structures intertwined with 
cationic lipid cylindrical micelles, the observed distances in the case of ionene 
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complexes suggest diameters of 1.2 and 1.4 nm for C2- and C6-ionene cylinders, 
respectively with a 2:1 hexagonal. These diameters seem reasonable for these 
molecules. 
Finding that SAXS measurements showed polyplex structures formed by the 
formulation based on C2- and C6-ionene and DNA salmon testes were similar, the 
polyplex made of C6:Luc oligonucleotide was chosen as a representative compound 
to carry out the corresponding dynamic light scattering (DLS) measurements. As 
illustrated in Fig. 39B, polyplexes were formed and showed an average diameter size 
of 320 ± 5 nm with good dispersity degree (0.3). Additionally, polyplexes based on 
C6-ionene were characterized by cryo-scanning electron microscopy (cryo-SEM) 
(Fig. 39C). The cryo-SEM analysis revealed spherical morphologies of the particles 
with similar average sizes (340 nm) than those achieved through the use of DLS, as 
previously described. These results show the appropriateness of the use of C6-
ionene polymer as a non-viral vehicle for nucleic acids (e.g. phosphorothioate and 
siRNA oligonucleotides). 
2.2.3 Cytotoxicity Assay 
Prior to transfection experiments, the cytotoxicity of polyplexes (containing the 
antisense oligonucleotide, Luc) derived from the different ionenes were tested on 
HeLa cells. Three concentrations were evaluated (60, 120 and 300 nM) with respect 
to Luc oligonucleotide at N/P ratios of 2, 4 and 6, respectively. As a control, the effect 
on HeLa cells viability of the three cationic vesicle formulations (DABCO-ionene, C2-
ionene and C6-ionene; mock) without forming complexes with Luc was also tested at 
0.6, 1.20 and 3.0 µM (concentrations that were used for the preparation of the 
polyplexes). Cells were incubated with the respective formulations at 37 °C for 24 h 
and normalized viabilities of treated cells with regard to untreated cells were 
measured by using a tetrazolium-based colorimetric (MTT) assay.181 
As displayed in Fig. 40, vesicle formulations that did not contain Luc oligonucleotide 
showed no cytotoxicity at the three concentrations tested (cellular viabilities > 90%). 
Also polyplexes containing 60 nM of Luc proofed to be harmless to HeLa cells at N/P 
ratios of 2, 4 and 6, respectively. At concentrations of 300 nM with respect to Luc 
those formulations derived from DABCO- and C2-ionene still showed perfect nontoxic 
behavior. However, those derived from C6-ionene based formulations showed a clear 
decrease in cell viability with rising N/P ratios (from N/P = 4: 78% to N/P = 6: 46%). 
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Fig. 40 Normalized cell viability of polyplexes derived from ionenes, antisense oligonucleotide and 
polysorbate 80. Toxicity of cationic vesicles without forming complexes was also tested. Polyplexes were 
tested at 60, 120 and 300 nM with N/P ratios of 2, 4 and 6. DABCO-ionene = blue colour, C2-ionene = red 
colour, C6-ionene = green colour. Each value represents the mean of at least 5 measurements. 
2.2.4 Transfection 
The described ionene-based formulations (DABCO-, C2- and C6-ionene) containing 
an antisense oligonucleotide (Luc), a 17-mer complementary to the mRNA Renilla 
luciferase gene, have been tested regarding their ability of silencing luciferase activity 
(Fig. 41). Generally, cationic particles are prone to interact with negatively charged 
proteins which may initiate aggregation processes leading to increasing particle sizes 
that may abolish the effectiveness of gene transfection.182 To avoid this undesirable 
effect, initial transfection experiments mediated by ionene formulations were 
evaluated in the absence of serum proteins (Fig. 41A). Thus, cationic polyplexes at 
concentrations of 120 nM with respect to Luc oligonucleotide at N/P ratios of 2 and 4 
(N/P ratio of 6 was dismissed according to MTT data) were prepared. 
Interestingly, two factors influenced the transfection process: the ionene structure 
and the relationship between ionene molar and charge ratio. According to Fig. 41A, 
the use of DABCO ionene-based formulation was detrimental in the transfection at 
the two N/P ratio tested probably due to the rigid linker which might have a 
detrimental effect on complex formation with oligonucleotides and therefore negative 
effect on mediating nucleic acid delivery. However, moderate gene silencing activities 
were obtained with cationic formulations at N/P ratio of 4 under serum-free conditions 
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at 120 nM with knockdown values of 40% and 27% for C2- and C6-ionene, 
respectively which inhibited luciferase production. This silencing activity, though 
modest, might come from the release and discharge of Luc oligonucleotide from 
endosomes probably by protonation mechanisms.183 
 
Fig. 41 Normalized gene-specific silencing activities targeting Renilla luciferase mRNA for polyplex 
formulations. (A) In the absence of FBS at different N/P ratios at 120 nM and (B) in the presence of FBS at 
concentrations of 60, 120 and 300 nM. Data are expressed as mean values of three replicates (± SD). 
As C2- and C6-ionene formulations at N/P ratio of 4 showed the best transfection 
profile and low toxicity at 120 nM, they were used for investigating the gene silencing 
abilities in the presence of 10% fetal bovine serum (FBS) (Fig. 41B) and at 
concentrations of 60, 120 and 300 nM with respect to Luc oligonucleotide. According 
to the results, transfection efficiencies strongly depended upon the presence of 
serum, which eagerly tended to interact with our two cationic polyplexes. This 
interaction resulted in decreasing the transfection efficiency of the formulations. Thus, 
while C2- and C6-ionene polyplexes silenced Renilla luciferase 40 and 27% at 
120 nM in the absence of FBS, the presence of FBS was detrimental on inhibiting 
luciferase at the same concentration. However, when the concentration of Luc 
oligonucleotide was increased up to 300 nM, both ionene formulations (C2- and C6-
ionene) were able to promote gene delivery with similar and significant efficiencies 
(48 and 38% luciferase inhibition for C2- and C6-ionene, respectively). (***p < 
0.0001). Interestingly, these silencing activities, though similar, were also found 
statistically significant in the case of C2-ionene formulations when compared to C6-
ionene formulations (*p < 0.05). It seems that a medium sized chain length of the 
linker has a beneficial effect on the transfection ability. Probably the right balance 
between rigidity and flexibility of the polymers must be found for optimal effects. 
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Additionally, a scramble (Scr) oligonucleotide complexed with C6-ionene formulation 
at the same N/P ratio of 4 together with C2- and C6-ionene formulations without 
forming polyplexes (mock) were used as controls and did not produce any effect on 
luciferase inhibition, as expected. Finally, to determine the specificity of the gene 
transfection process, Luc and Scr oligonucleotides were formulated into liposomes as 
controls (in the presence of lipofectamine) obtaining similar inhibition results as 
previously reported (data no shown).184 
2.3 Materials and Methods  
2.3.1 Materials 
Polysorbate 80 (Tween 80), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT reagent), sodium salt of DNA from salmon testes (polymerization 
average degree of 2000 base pairs) and antisense oligonucleotide of sequence (5’-
CGT TTC CTT TGT TCT GGA-3; Luc’) were purchased from Sigma-Aldrich (St. 
Louis, Missouri, United States) and used as received. A scramble sequence (5’-CTG 
TCT GAC GTT CTT TGT-3’; Scr) was synthesized in house and purified by DMToff-
based protocols. Lipofectamine 2000 was purchased from Invitrogen (Carlsbad, 
California, United States). PBS buffer and Dulbecco’s Modified Eagle’s Medium 
(DMEM), which was supplemented with a 10% heat-inactive fetal serum bovine 
(FBS) along with distilled water (DNAse/RNAse free) were purchased from Gibco 
(Waltham, Massachusetts, United States). Additional nuclease-free water was also 
prepared by using 0.1% of diethylpyrocarbonate (DEPC) to ensure the removal of 
RNase contamination, autoclaved and filtered before using. Luciferase assay kits 
were purchased from Promega (Madison, Wisconsin, United States). Qiagen Giga 
plasmid purification kit was purchased from Qiagen (Hilden, Germany). Starting 
materials for polymer synthesis were purchased from Sigma Aldrich (St. Louis, 
Missouri, United States) or TCI (Zwijndrecht, Belgium). Luminiscence values were 
measured in a Promega Glomax Multidetection instrument (Madison, Wisconsin, 
United States). All ionene polymers were synthesized by step-growth polymerization 
following the two-step procedure previously described and showed the same 
spectroscopic data.151,153,171,185 In short, reaction of o-phenylenediamine with 
4-(chloromethyl)benzoyl chloride in the presence of Et3N in DCM afforded the 
corresponding bis-benzamides in good yields (75%–98%). Subsequent copoly-
merization with equimolar amounts of the desired α,ω-diamine in dimethylformamide 
(DMF) at 80 °C provided white precipitates within 2–6 days. The precipitates were 
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filtered, washed (with DMF, MeCN and DCM) and dried under vacuum to afford the 
ionenes in modest yields (43%–80%). Sufficient solubility for gel permeation 
chromatography (GPC) was achieved by exchanging the chloride anions by 
bis(trifluoromethanesulfonyl)amide (TFSA) anions using lithium bis(trifluoromethane-
sulfonyl)azanide (LiTFSA) in hot water. These ionenes·TFSA showed low degrees of 
polymerization (n = 7–14) and high dispersity values (Đ = 2.1–3.1). Weight-average 
molecular weights, Mw (Da), for ionenes·TFSA: 8.1 x 103 (DABCO-ionene); 1.6 x 104 
(C2-ionene); 6.9 x 104 (C6-ionene); number-average molecular weight, Mn (Da), for 
ionenes·TFSA: 3.9 x 103 (DABCO-ionene); 6.1 x 103 (C2-ionene); 2.2 x 103 (C6-
ionene). 
2.3.2 Preparation of Polyplexes 
Cationic vesicles were prepared by mixing ionenes (1 – 2 mg) and polysorbate 80 in 
a 1:1 (n/n) molar ratio and dissolving/suspending those in MilliQ water (1 mL). 
Mixtures were dried in speed vacuum at 45 °C for 18 h. The resulting film was 
rehydrated in 1 mL of sterile HEPES buffer (20 mM, pH 7.4), incubated at 60 °C for 
20 min, sonicated for 3 min and filtered through a 13 mm Nylon filter with 0.2 µm pore 
width. Polyplexes were obtained by adding an oligonucleotide stock solution to the 
cationic vesicle solutions to give N/P ratios ([cationic amino groups]ionene/[anionic 
phosphate groups]nucleic acid) between 0.05 and 8. The mixtures were vortexed, 
sonicated for 10 s and finally incubated at 37 °C for 30 min. 
The synthesized ionene monomers each contain two terminal amine groups which 
will found positively charged at physiological pH conditions (7.4). The antisense 
oligonucleotide (Luc oligonucleotide) contains 17 negative charges and the N/P ratio 
can be calculated by using eq. 1, as described elsewhere.186 
𝑁
𝑃
𝑟𝑎𝑡𝑖𝑜 =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑚𝑜𝑙𝑒𝑠 𝑜𝑓 𝑖𝑜𝑛𝑒𝑛𝑒 𝑚𝑜𝑛𝑜𝑚𝑒𝑟 𝑥2
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑚𝑜𝑙𝑒𝑠 𝑜𝑓 𝐿𝑢𝑐 𝑜𝑙𝑖𝑐𝑜𝑛𝑢𝑐𝑙𝑒𝑜𝑡𝑖𝑑𝑒 𝑥 17
   (1) 
2.3.3 Zeta-Potential 
Zeta potential values were obtained by laser doppler velocimetry by using a Zetasizer 
Nano ZS (Malvern Instruments; Malvern, United Kingdom) equipped with a He–Ne 
red light laser (λ = 633 nm). Polyplex solutions were measured at an oligonucleotide 
concentration of 0.5 µM and N/P ratios from 0.05 to 6 at 25 °C. Samples (50 µL) were 
diluted in 0.1 mM NaCl solution (950 µL) and introduced into folded capillary cells. 
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Smoluchowsky approximation was used to calculate zeta potential values. 
Measurements were run in triplicate. 
2.3.4 Size Measurements 
The hydrodynamic diameter of polyplexes (cationic ionene/DNA complexes) was 
determined by dynamic light scattering (DLS) spectrometer (LS Instruments, 3D-
cross correlation multiple scattering) equipped with a He–Ne laser (632.8 nm). 
Measurements were carried out at a scattering angle of 90°, in triplicates at 25 °C 
without sonication. The particle radii were calculated by fitting the first cumulant 
parameter. 
2.3.5 Small-Angle X-Ray Scattering (SAXS) Measurements of Ionene Polyplexes 
Small-angle X-ray scattering measurements were recorded on S3-MICRO (Hecus X-
ray system, GMBH Graz, Austria) which was coupled to a GENIX-Fox 3D X-ray 
source (Xenox, Grenoble) and coupled with a 3D focusing mirror that produces a 
detector-focused X-ray beam with ʎ = 0.1542 nm Cu Kα-line (greater than 97% purity 
and less than 0.3% of Kα). Transmitted scattering was measured by using a PSD 50 
Hecus in the SAXS regime (0.09 nm-1 < q < 6 nm-1) including Bragg peaks and 
diffuse scattering. Measurements were carried out at a constant temperature (25 °C) 
for 24 h. Detector counting was accumulated for 20 min intervals, if no temporal 
variation was observed, several runs were summed up to reduce the noise of 
background level. A stock concentration of DNA from salmon testes in 20 mM 
HEPES (pH 7.4) was properly mixed with a stock concentration of a surfactant-
ionene formulation in 20 mM HEPES buffer at 37 °C for 30 min. The resultant 
polyplexes (DNA:ionene complexes) were isolated, dried and deposited in a glass 
capillary of 1 mm diameter with 10 µm wall thickness. SAXS scattering curves were 
plotted as a function of the scattering vector modulus (eq. 2) where  is the scattering 
angle and λ the incident radiation wavelength is. A silver behenate sample was used 
in order to calibrate the system scattering vector. 
𝑞 =
4𝜋
𝜆
𝑥 𝑠𝑖𝑛
𝜃
2
      (2) 
 
2.3.6 cryo-Scanning Electron Microscopy (cryo-SEM) 
Polyplexes made of ionene-C6 based formulation and Luc oligonucleotide were 
obtained at N/P ratio of 4. The resultant polyplexes were rapidly frozen in liquid 
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nitrogen and cut with an equipped cold knife. Polyplexes were sputtered with gold-
palladium, observed and processed by using a Hitachi S-3500N (Hitachi High-
Technologies Corp., Tokyo, Japan) scanning electron microscope operated at 5 kV. 
2.3.7 Cytotoxicity Assay 
The adherent cell line HeLa (human carcinoma) was plated at a density of 5  103 
cells/well (50% confluency) on a 96-well plate in 200 µL of Dulbecco's Modified 
Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), in the 
absence of antibiotics. HeLa cells were incubated at 37 °C in a humidified 
atmosphere (5% CO2) for 24 h to permit cell attachment. Then the medium was 
removed and replaced by fresh one to give a final concentration of 200 µl. Polyplexes 
and cationic vesicles were prepared as described above and added to the wells to 
give concentrations of 60, 120 and 300 nM and N/P ratios of 2, 4 and 6. The mixture 
was incubated at 37 °C for 18 h and then medium was removed and the wells were 
washed with PBS (1  200 µL). Fresh DMEM was added (200 µL) and cells were 
incubated again at 37 °C for 3 h. MTT solution (10 µL, 5 g L-1 in PBS buffer) was 
added to each well and plates were stored at 37 °C for further 2.5 h. Then medium 
was removed, DMSO (100 µL) was added and absorbance was measured at 
570 nm. Each measurement was performed with 6 replicates. 
2.3.8 Gene Transfection and Antisense Technology Studies 
In the Absence of FBS 
HeLa cells were regularly passaged to maintain exponential growth. Cells were 
seeded the day before at a density of 105 cells/well on a 24-well plate each well in 
DMEM supplemented with 10% FBS. Cells were incubated at 37 °C for 18 h in a 
humidified atmosphere (5% CO2) to permit cell attachment. The medium was then 
replaced by fresh one (500 µL). A solution containing firefly luciferase (pGL4) (30 µL, 
100 ng µL-1) and Renilla luciferase (30 µL, 10 ng µL-1) in Opti-MEM™ (90 µL) was 
combined to a solution containing Lipofectamine2000 (3.9 µL, 1 g L-1) in Opti-MEM™ 
(146.4 µL). The resultant formulation was incubated 10 min at room temperature. To 
each well 100 µl of this formulation was added and the cells were incubated at 37 °C 
for 6 h. Medium was removed, cells were washed with PBS (2  400 µL) and DMEM 
without FBS was added (500 µL). Polyplexes were added (100 µl) to give final 
oligonucleotide concentrations of 120 nM and N/P ratios of 2, 4 and 6 and cells were 
incubated at 37 °C for 24 h. Medium was removed, cells were washed with PBS 
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(1  500 µL) and cells were stored at 20 °C for 18 h. After thawing the cells 100 µL 
of lysis buffer were added to each well. The plate was shaken at 480 rpm at room 
temperature for 15 min. Lysates (25 µL) were transferred to a 96-well plate and 
luminescence was recorded after adding, alternatingly, Luciferase assay reagent 
(25 µL) and Stop&Glow reagent (25 µL). Inhibition results generated by polyplex-
based ionenes were expressed as normalized ratios between the reported luciferase 
(Renilla) and control luciferase (Firefly). Luc and Scr oligonucleotides at 60 nM were 
formulated into liposomes (in the presence of lipofectamine) as positive and negative 
controls, respectively.   
Statistical Analysis. Data were shown as mean ± standard deviation (SD) and are the 
result of an average of three replicates. Statistical differences were determined by 
using Student’s t-test and were considered significant when *p < 0.05 and ***p < 
0.001. 
In the Presence of FBS 
HeLa cells were regularly passaged to maintain exponential growth. Cells were 
seeded the day before at a density of 105 cells/well on a 24-well plate each well in 
DMEM supplemented with 10% FBS. Cells were incubated at 37 °C for 18 h. Renilla 
and Firefly luciferases were transfected following the same procedure as described 
above. After 6 h incubation at 37 °C, medium was removed, cells were washed with 
PBS (2  400 µL) and DMEM supplemented with 10% FBS was added (500 µL). 
Polyplexes were added to give a final N/P ratio of 4 and oligonucleotide 
concentrations of 60, 120 and 300 nM. Cells were incubated at 37 °C for 24 h. 
Medium was removed, cells were washed with PBS (1  500 µL) and stored at 
20 °C for 18 h. After thawing the cells, 100 µL of lysis buffer were added to each 
well. Luminiscence was measured following the same protocol as described before. 
Inhibition results generated by polyplex-based ionenes were expressed as 
normalized ratios between the reported luciferase (Renilla) and control luciferase 
(Firefly). 
2.4 Conclusions 
Cationic vesicles derived from ionene polymers with alternating α,ω-tertiary diamine 
linker and the non-ionic surfactant polysorbate 80 were used to entrap 
oligonucleotide single strands which were complementary to Renilla luciferase 
mRNA. Zeta-potential of the vesicle formulations at different N/P ratios ([cationic 
amino groups]ionene/[anionic phosphate groups]nucleic acid) was measured to ensure a 
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positive charge of the system. MTT assay showed no toxicity for formulations derived 
from DABCO- and C2-ionene at several concentrations and N/P ratios (2, 4 and 6) 
whereas C6-ionene showed critical cell viabilities at 300 nM with a N/P ratio of 6 (46% 
of cell viability). Transfection experiments of all cationic vesicle formulation were 
investigated by performing a luciferase activity assay at 120 nM and N/P ratios of 2 
and 4 in the absence of proteins. As a result, DABCO-ionene derived formulations 
showed no transfection ability at both N/P ratios tested. On the contrast for C2- and 
C6-ionene derived formulations showed perfect non-toxic behaviour, the luciferase 
activity was reduced by 48 and 38%, respectively at N/P ratio of 4 and Luc 
concentration of 300 nM. The use of this complete harmless formulation at higher 
concentrations might be an interesting alternative to current transfection agents and 
further structure-activity relationship need to be carried out in order to obtain 
optimized cationic ionene derivatives that are less susceptible to FBS proteins. 
Further studies to determine the effect of the polymer topology (positional isomers) 
on the transfection efficiency are currently undergoing in our laboratories and the 
results will be reported at due course. 
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3. Aromatic ionene topology and counterion-tuned gelation of acidic aqueous 
solutions5 
3.1 Introduction 
A large number of important biological macromolecules (e.g. nucleic acids, 
polypeptides and polysaccharides) and well-known synthetic macromolecules (e.g. 
polyacrylic acid and poly(styrene sulfonate)) are highly charged polymers, so-called 
polyelectrolytes, that have been object of abundant theoretical and experimental 
investigations during the last few decades.187–189 Commercial applications of these 
polymers range from colloidal stabilization to superabsorbent gels, where 
hydrophobic, charge transfer and long-ranged electrostatic interactions mediated by 
mobile ions and water molecules define the physical properties and, hence, the 
functionality of these systems. 
Among different types of polyelectrolytes, polycations bearing quaternary ammonium 
in the backbone constitute a very interesting subgroup known as ionenes,138,190–195 
which are usually prepared either by step polymerization via Menshutkin reaction or 
cationic functionalization of precursor polymers.140,141,196,197 These polymers have 
been widely used as antibacterial agents, building blocks for the preparation of 
chromatography stationary phases, simplexes or functional gels, among other 
applications.190,198,199 The charge distribution, the type of counterions, the molecular 
weight, structural flexibility and H-bonding capability are, among others, critical 
aspects that may influence the dynamics of the ionic chains that govern their 
properties.200–202 Unfortunately, a low control on some of these features as well as 
the lack of theoretical models developed at the atomistic level203–206 make it difficult to 
understand, predict and control their aggregation in different aqueous media.203 
Within this context, we have recently reported151 a combined computational-
experimental approach that led to the improvement of the hydrogelation ability of 
important 1,4-diazabicyclo[2.2.2]octane (DABCO)-based ionenes152,187–189,207 contai-
ning different structural isomers of phenylenediamine as molecular core (Fig. 42).  
                                            
 
5 Adapted from Ref. 215 with permission from The Royal Society of Chemistry. Synthesis of ionenes 
was performed by J. Bachl and J. Mayr. Gelation vs. HCl conc. experiments, rheology and polarized 
light photos were made by J. Bachl. Gelation experiments in other acidic and salt solutions and HCl 
gas adsorption was performed by J. Mayr. Computer simulations were performed by O. Bertran. 
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Fig. 42 Structures of topologically different water and acidic solutions gelling ionene polymers ortho-, 
meta- and para-DABCO. 
Molecular dynamics simulations of these ionenes with explicit water molecules 
pointed out remarkable differences in the assembly of the polymeric chains in each 
case. Specifically, interchain regions with high degree of hydration (i.e. 
polymer ··· water interactions) and regions dominated by polymer···polymer 
interactions were evident in the case of o-DABCO and m-DABCO isomeric ionenes, 
while domains governed by polymer ··· polymer interactions were nearly inexistent in 
p-DABCO. This was experimentally correlated with the superior properties of the gels 
prepared from o-DABCO.151 
Despite the potential interest of gelation of acidic solutions in areas such as safety 
and environmental remediation,208,209 this phenomenon is scarcely described in the 
literature and mainly associated to low molecular weight gelators.210–213 A reason 
behind this scenario may be the existence of labile structural moieties in many 
gelating agents and their potential cleavage and/or undesired protonation events in 
acidic media. Yoshida and co-workers152 reported that a polymer based on a N,Nˈ-
(p-phenylene) dibenzamide linkage bearing a C6-flexible spacer was able to gel a 
0.1 M HCl solution, although no further studies were carried out related to this 
observation. To our delight, we have found that the well-defined topology of ionenes 
187,189,190 not only govern their aggregation behaviour in pure water but also in a 
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variety of aqueous acidic solutions leading to the formation of a variety of stable 
acidic gels. Herein, we describe the details of this exceptional phenomenon and the 
understanding of the effects of the different polymer topologies through computa-
tional molecular dynamic simulations. 
3.2 Results and Discussion 
3.2.1 Gelation properties in aqueous acidic and salt solutions 
During the study of the gelation ability of the ionenes we found that o-DABCO and 
p-DABCO efficiently gelled HCl solutions (0.1 M, pH = 1.0) at their corresponding 
CGC determined in pure water (25 g L-1 and 48 g L-1, respectively). In contrast, 
m-DABCO failed to gel these HCl solutions even at 2-fold higher gelator 
concentration (up to 200 g L-1) than that in pure water.  
Table 2 Effect of different aqueous environments containing various acids and inorganic Cl- sources on the 
gelation properties of ionenes with respect to pure watera 
 
a Experimental errors were determined from at least two randomized measurements. b Unless otherwise 
indicated, the concentration of aqueous solutions was adjusted to 0.1 M. c Concentration was adjusted to 
0.05 M. d Gradual water loss of the material precluded an accurate determination of the Tgel. Abbreviations: 
I = insoluble, S = solution, P = precipitate. 
As shown in Table 2, further investigations revealed that o-DABCO and p-DABCO 
were also able to promote effective gelation of 0.1 M HCl solutions not only at 
concentrations even lower than the CGC established in pure water, but also with 
much faster kinetics (about 100-times and 50-times shorter gelation times than in 
water for o-DABCO and p-DABCO, respectively). Motivated by these results, we 
CGC          Gel-time T gel CGC      Gel-time T gel CGC   Gel-time T gel 
(g L
-1
) (min) (ºC) (g L
-1
) (min) (ºC) (g L
-1
) (min) (ºC)
H2O 25 ± 2 1080 ± 60 56 ± 1 100 ± 10 1260 ± 40 59 ± 1 48 ± 5 2640 ± 240 49 ± 1
HCl 22 ± 2 10 ± 2 60 ± 2 S - - 33 ± 3 50 ± 5 63 ± 1
HBr 56 ± 2 11 ± 5 44 ± 1 170 ± 30 1 ± 0.5 - 
d 58 ± 3 30 ± 10 34 ± 4
HI 68 ± 3 6 ± 1 41 ± 2 59 ± 9 420 ± 60 32 ± 2 I - -
H3PO4 46 ± 4 20 ± 2 76 ± 1 S - - 105 ± 11 68 ± 8 55± 2
HNO3 46 ± 1 30 ± 5 35 ± 1 139 ± 29 4 ± 1 - 
d 88 ± 2 15 ± 1 - 
d
H2SO4 S - - S - - S - -
CH3COOH 48 ± 4 5 ± 1 61 ± 2 S - - 110 ± 10 30 ± 5 33 ± 2
HCOOH 45 ± 1 90 ± 20 57 ± 2 150 ± 50 3 ± 1 - 
d 68 ± 1 140 ± 20 67 ± 7
NaCl 92 ± 9 6 ± 1 54 ± 3 P - - P - -
CsCl 97 ± 9 3 ± 1 53 ± 2 P - - P - -
NH4Cl 100 ± 10 4 ± 1 63 ± 2 P - - P - -
CaCl2
 c 89 ± 9 4 ± 1 36 ± 2 P - - P - -
Aqueous 
medium
b
o-DABCO m-DABCO p-DABCO
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decided to explore the gelation ability of these systems in other acidic solutions. 
O-DABCO formed stable and homogeneous gels within 30 min in HBr, HI, H3PO4 
and HNO3 solutions (0.1 M, pH = 1.0 for HBr, HI, and HNO3, pH = 1.62 H3PO4), 
whereas the gelation ability of m-DABCO and p-DABCO was rather limited and 
several of their gels were not homogeneous and underwent gradual water loss over 
time (Table 2 and Fig. 43).  
 
Fig. 43 Appearance of the inhomogeneous gels and undissolved solid material obtained m-DABCO in 
different acidic solutions. 
No gelation was observed in H2SO4 (0.1 M, pH = 0.96) for any of the ionenes, which 
led to turbid solutions at concentrations ranging between 10 g L-1 and 200 g L-1. 
Remarkably, o-DABCO and p-DABCO also showed the capacity to form stable gels 
in solutions of organic acids such as acetic acid (CH3COOH, 0.1 M, pH = 2.87) and 
formic acid (HCOOH, 0.1 M, pH = 2.37), being o-DABCO the most efficient gelator in 
terms of gelation concentration, kinetics and/or thermal stability of the gels. In terms 
of optical appearance, and in contrast to the hydrogel obtained from o-DABCO in 
water, all gels described in Table 2 were opaque except the one made of o-DABCO 
in acetic acid, which was translucent. These appearances suggested the formation of 
aggregates in acidic solutions bigger than the wavelength of visible light (350 –
750 nm) causing its scattering. The acidic gels prepared from o-DABCO were stable 
for several months at room temperature without detriment of their consistency and 
visual appearance. 
At this point we decided to take HCl solution as a model acidic medium to investigate 
and compare other properties of the obtained gels compared to those prepared in 
pure water. An important effect of the Cl- counterion was revealed by the ability of 
o-DABCO to gel also solutions of different ionic strengths containing inorganic 
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chloride salts such as NaCl, CsCl, NH4Cl (pH = 5.1) and CaCl2, albeit the use of 3.5 –
4 fold excess in gelator concentration compared to the CGC in pure water was 
necessary to obtain the gels (Table 2). The superior gelation properties of o-DABCO 
were also evident in these solutions as neither m-DABCO nor p-DABCO were able 
to form gels at concentrations ranging from 10 g L-1 and 200 g L-1. These results 
suggest an apparent synergistic effect of both H+ and Cl- ions to facilitate the gelation 
process using o-DABCO, thus lowering the CGC and increasing the stability of the 
resulting gel in comparison to pure water. 
Additional positive effects of the HCl medium were obvious by comparing the gelation 
kinetics and the thermal stabilities of gels with those obtained in pure water at 
comparable ionene concentrations (Fig. 44). Thermal sol-to-gel transition 
temperatures (Tgel) of the gels prepared from o-DABCO and p-DABCO were found 
to be increased by 4 °C and 14 °C, respectively, with respect to those obtained in 
water (Fig. 44A). Furthermore, a remarkable decrease in the gelation time to about 
20% of the value obtained in water was visible for both o-DABCO and p-DABCO in 
HCl solutions (Fig. 44B).  
 
Fig. 44 Effect of HCl concentration on typical gelation properties A) Tgel; B) gelation time of ionenes o-
DABCO and p-DABCO at their CGC in water as indicated in  
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Table 3 Effect of the concentration of HCl on the gelation kinetics, Tgel and optical appearance of the gels 
made from o-DABCO and p-DABCO at their CGC in water as indicated in Table 1.a 
Concentration Gelation time (min) Tgel (°C) Optical appearance 
HCl (M) o-DABCO p-DABCO o-DABCO p-DABCO o-DABCO p-DABCO 
0.0 1080 ± 60 2640 ± 240 56 ± 1 49 ± 1 TG OG 
0.1 20 ± 2 50 ± 5 60 ± 2 63 ± 1 OG OG 
0.25 20 ± 5 65 ± 5 59 ± 1 56 ± 2 OG OG 
0.5 40 ± 5 180 ± 15 51 ± 1 43 ± 2 OG OG 
1.0 140 ± 20 S 42 ± 2 S WG S 
2.0 S S S S S S 
a Experimental errors were determined from at least two randomized measurements. Abbreviations: S = 
solution; TG = transparent gel; OG = opaque gel; WG = weak gel (i.e. exhibits gravitational flow after 
inverting a test tube within 30 min).  
The optimum concentration of HCl in aqueous solution was determined by testing 
different concentrations at the CGC of the desired gelator in pure water, and 
comparing the effect on both the Tgel and the gelation kinetics. The results are 
summarized in Table 3 and Fig. 44 and indicate that a concentration of HCl of 0.1 M 
promotes the most effective gelation characterized by the highest Tgel and gelation 
kinetics for both ionenes. Gels made from o-DABCO and p-DABCO could also be 
prepared at acid concentrations of 1.0 M and 0.5 M, respectively, albeit with a 
detriment of the studied gels properties. Higher concentrations in each case lead to 
clear viscous solutions. In addition, and as also observed in pure water,151 both the 
thermal stability of the gels and the gelation kinetics in acidic medium were enhanced 
by increasing the ionene concentration (e.g. gel prepared from o-DABCO in 0.1 M 
HCl at its CGC displayed a Tgel of 60 ± 2 °C and a gelation time of 10 ± 2 min, 
whereas around 4-fold increase in the concentration of the ionene afforded an 
opaque gel within 4 ± 0.2 min and with a Tgel of 72 ± 1 °C) (Table 3). 
Dynamic oscillatory rheology was conducted in order to confirm the viscoelastic 
gel nature of the materials and compare the overall mechanical stabilities towards 
external shear forces. Appropriate dynamic frequency sweep (DFS), dynamic strain 
sweep (DSS) and dynamic time sweep (DTS) experiments for the gels made of o-
DABCO and p-DABCO both in water and in HCl solutions revealed a remarkable 
enhancement of the mechanical stabilities of the gels prepared in HCl, as indicated 
by higher storage modulus G0 (one order of magnitude higher than in water) and 
lower tan δ values. On the other hand, the materials derived from HCl seem to be 
more brittle in nature as indicated by the smaller maximum strain at break (γ) of the 
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gels. Furthermore, the macroscopic thixotropic behaviour of o-DABCO that we 
previously observed in water151 is also preserved in 0.1 M HCl solution and supported 
by a three-step loop test (i.e. >97% of the original moduli values was recovered after 
the second relaxation cycle) performed. 
Optical microscopy images of the gels made of o-DABCO (25 g L-1) in both 0.1 M 
HCl and pure water revealed the presence of distinctive domains of birefringence 
under crossed nicols dependent on the nature of the aqueous medium, indicating the 
formation of different anisotropic aggregates (Fig. 45A–D). FESEM images of the 
corresponding xerogels, obtained by the freeze-drying method,214 confirmed the 
induction of different morphologies caused by the nature of the aqueous 
environment. 
 
Fig. 45 Optical and morphological features of hydrogels prepared from o-DABCO and p-DABCO at their 
CGC in water. A, B) Optical images under crossed nicols of the gel film made from o-DABCO in water. 
Magnification: A = 10; B = 50. C, D) Optical images under crossed nicols of the gel film made from o-
DABCO in 0.1 M HCl. Magnification: C = 10; D = 50. Note: Apparent higher birefringence density for 
gel-materials in acidic environment suggests the formation of more extended networks as compared to 
pure hydrogels, which is in agreement with their higher mechanical and thermal resistance. E) FESEM 
image of the xerogel derived from the gel made from o-DABCO in water. F) FESEM image of the xerogel 
derived from the gel made from p-DABCO in water. G) FESEM image of the xerogel derived from the gel 
made from o-DABCO in 0.1 M HCl. H) FESEM image of the xerogel derived from the gel made from p-
DABCO in 0.1 M HCl. I) TEM image of the gel made from o-DABCO in water. J) TEM image of the 
xerogel derived from o-DABCO in 0.1 M HCl. K-L) TEM image and elemental analysis profile, 
respectively, of cubic structures (average edge lengths of around 515 μm) of NaCl obtained from 
compound o-DABCO (25 g L-1) in 0.1 M HCl solution. Such NaCl crystals were presumably formed during 
the preparation process of the gels/xerogels or during an aging process involving traces of Na+ cations still 
present in the used purified water. 
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Specifically, dense and macroporous networks formed by connected leaf-like layers 
with interlamellar distances in a range of 5–10 mm were visualized for the xerogels of 
o-DABCO and p-DABCO in pure water (Fig. 45E and F). In sharp contrast, rougher 
and denser agglomerates could be observed for xerogels made of both ionenes in 
0.1 M HCl (Fig. 45G and H). Agglomerates resembling pebble stones (average 
diameter for individual particles ~ 1–5 mm) were clearly characteristic for xerogels 
prepared from ionene p-DABCO (Fig. 45H). TEM images derived from compound o-
DABCO in pure water revealed overlapped lamellar structures consisting of large and 
homogeneous sheets (Fig. 45I), in good agreement with the findings obtained by 
FESEM. On the other hand, TEM images of the materials derived from acidic 
environment showed the presence of very dense and non-layered structures (Fig. 
45J). 
3.2.2 Computer Simulations 
Molecular dynamics (MD) simulations of ionenes were performed considering an 
aqueous solution containing 1000 H3O+·Cl- ion pairs to provide microscopic 
information about the relationships between the substitution pattern of the phenyl ring 
and the gelation capacity in acidic solutions. Visual inspection of the recorded 
snapshots reveals important differences between the three systems (Fig. 46).  
 
Fig. 46 Last snapshot of the MD simulations performed for o-DABCO, m-DABCO and p-DABCO. 
First, the degree of assembly among the polymer chains is different for the three 
ionenes. Thus, polymer ··· polymer interactions dominate on o-DABCO while the 
dimensions of the internal hydration areas progressively increase for m-DABCO and, 
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especially, p-DABCO. Indeed, polymer ··· polymer interactions are mainly localized 
at the central region for the latter. Thus, o-DABCO dominates with respect to the 
other two systems not only in terms of specific interactions (e.g. hydrogen bonds, 
N-H ··· π and π-π), as proved below, but also in van der Waals forces (i.e. steric 
contacts among the polymer chains).  
3.2.3 HCl gas adsorption 
Furthermore we investigated the ability of hydrogels from o-DABCO to absorb acidic 
gases by leading a flow of in situ generated HCl over those hydrogels (Fig. 47). 
Comparison between the use of pure water or hydrogel as absorbing media (Table 4 
entry 1 and 2 or 3 and 4 respectively) shows the hydrogel reveals slightly lower 
absorption ability.   
Table 4 Conditions for HCl adsorption experiments with hydrogels derived from o-DABCO. 
      
Fig. 47 Experimental setup for the determination of HCl absorption. 
Increasing the amount of generated HCl by 4 and prolonging the time period of 
experiment by a factor of 3 leads (  
Table 4 entry 1 and 3 or 2 and 4 respectively) leads to an increase of relative 
absorption by 9.6% and 8.9%, respectively. Varying the concentration of gelator did 
not lead to a significant difference in absorption. Additionally we could observe HCl 
absorption by the ionene powder itself which proofs an interaction of polymer and 
HCl gas. 
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3.3. Experimental Part 
3.3.1 Gelation of aqueous acidic solutions 
CGC values were estimated by continuously adding aliquots of aqueous solution or 
water (0.02 - 0.1 mL), respectively into vials containing solid ionenes and performing 
a typical heating-cooling protocol for gel-formation until no gelation was observed. 
The starting point for CGC determinations was 200 g L-1. The time that was 
necessary for gel formation was measured by turning the vials upside down and the 
point where no flow occurred was considered as being the gelation time. After resting 
overnight, the samples were heated in a custom made heating block at a rate of 
about 2 °C / 5 min. Melting points were measured by inverse flow method.  
3.3.2 HCl gas adsorption 
In a 50 mL Schlenk flask a hydrogel derived from o-DABCO (225 or 500 mg in 5 mL) 
was prepared by a classical heating-cooling protocol. After chilling for 90 min, in situ 
generated HCl gas was led over the gel. (HCl generation by addition of conc. H2SO4 
to NaCl). After finishing the gas flow, the gel was transferred quantitatively, with the 
help of water, to a beaker and the absorbed amount of HCl was determined by 
titration against 0.1 M NaOH. As control, the same experiment was carried out with 
5 mL of pure water. 
3.4 Conclusions 
The challenging gelation of acidic solutions was achieved using polycations bearing 
quaternary ammonium moieties. These ionene polymers were synthesized from a 
disubstituted phenylene dibenzamide core, which allows the construction of different 
topomers (i.e. o-DABCO, m-DABCO and p-DABCO). Remarkably, the topology of 
the polymers was found to play a crucial role on their aggregation behaviour both in 
pure water and in a variety of aqueous acidic solutions leading to the formation of 
uncommon acidic gels. In particular, o-DABCO showed superior gelation ability than 
the analogues m-DABCO and p-DABCO in solutions of different pH and ionic 
strengths. In terms of gel properties, lower critical gelation concentrations, higher gel-
to-sol transition temperatures and faster gelation were routinely observed for o-
DABCO topomer. Finally, atomistic MD simulations on huge models have allowed to 
conclude that the distinctive properties of o-DABCO are due to the formation of 
specific polymer ··· polymer interactions (i.e. hydrogen bonds, N–H ··· π and intra-
molecular π – π stacking), which are facilitated by the binder effect of Cl- counterions. 
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Both the formation of intramolecular π – π stacking networks and the role of the Cl- in 
the stabilization of specific polymer ··· polymer interactions are singular trends with 
respect to m-DABCO and p-DABCO. Thus, the ortho topology favours both the 
contact among polymer chains and, therefore, the formation of small internal 
hydration regions. This synergistic combination, which is not possible for the m-
DABCO and p-DABCO, is responsible of the role played by Cl– counterions in the 
superior gelation of the former. Finally, differences between the two latter ionenes 
have been attributed to the greater strength of intermolecular π – π stacking in m-
DABCO.  
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D   Summary 
In this dissertation the synthesis, characterization and application of smart materials 
based on low-molecular-weight compounds as well as polymers is described. The 
first half of this thesis (chapter B) deals with a selection of low molecular weight 
gelators with either synthetic or natural origin.  
The first section (chapter B1) presents the transfer of a concept which is 
originally used for the design of new drug molecules, to the rational development of 
new gelator compounds, namely the isosteric replacement. Here the substitution of 
the amide function in N-stearoyl-L-glutamic acid (C18-Glu) (see Fig. 48) – a 
compound which is known to be able to act as gelator for several solvents – was 
replaced by a 1,4-disubstituted 1,2,3-triazole unit (click-Glu) and a sulfonamide 
(sulfo-Glu), respectively. In both cases the total number of C atoms has formally been 
kept intact. 
 
Fig. 48 L-glutamic acid derived gelator molecules described in chapter B1. 
In terms of gelation of a range of different organic solvents, as well as water, it was 
found that click-Glu revealed superior features with respect to the CGC, Tgel and 
mechanical stability in polar protic solvents, whereas sulfo-Glu exhibited improved 
properties in non-polar solvents and C18-Glu showed in average values between 
those of click-Glu and sulfo-Glu. But not only the characterization of the gel material 
itself was described but also the successful application of hydrogels derived from all 
three glutamic acid derivatives as carriers of several hydrophilic and hydrophobic 
drugs and the subsequent release over a period up to two weeks could be 
demonstrated which revealed the influence of the functional group in the respective 
gelator molecules on the release rate of the drugs. 
  
Summary 
80 
 
Chapter B2 describes the application of hydrogels, derived from glycyrrhizic acid 
ammonium salt, as drug depot. Glycyrrhizic acid ammonium salt is a salt of 
glycyrrhizin, a natural compound which can be extracted from the licorice root.  
 
Fig. 49 Structure of glycyrrhizic acid. 
It exhibits an excellent biocompatibility, which is why it was chosen for the formulation 
and drug release study of three anti-cancer agents of different hydrophilicity. The 
influence of drug inherent hydrophilicity as well as the pH and nature of the release 
medium on the drug diffusion rate was investigated. In good agreement with previous 
publications, more hydrophobic compounds were found to tend to a slower diffusion 
into the release medium as they experience a greater retention from the gel 
environment. In terms of pH of surrounding medium, the release into more basic 
solutions was found to be faster as high pH values seemed to destabilize the integrity 
of the gel network. However the nature of the release buffer (e.g. organic or 
inorganic) also played an important role, which makes a forecast of the release 
kinetics, depending on the pH difficult and therefor demonstrates the limitations of in 
vitro drug delivery experiments. Nevertheless, preliminary release studies provide 
important information necessary for the design of in vivo experiments. 
A formamidine based low molecular weight compound and its gelation 
properties are presented in chapter B3. The amphiphilic molecule consists of a long 
chain containing 16 carbon atoms and an acetyl L-phenyl alanine connected via a 
formamidine group. 
 
Fig. 50 Formamidine based, amphiphilic gelator compound. 
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This molecule is able to form gels in a variety of different organic solvents as well as 
two ionic liquids and water. It was found that ultrasonication of an isotropic solution of 
the gelator led to superior materials in comparison to gels prepared by the classical 
heating and spontaneous cooling of gelator solution. Furthermore temperature 
controlled 1H-NMR reveled the participation of H-bonding, π - π-stacking, as well as 
van-der-Waals interactions in the gelation process. Moreover the temperature 
controlled turning on/off of birefringence of a gel in MeCN could be demonstrated, 
which constitutes an important property for potential applications in optical devices. 
Unfortunately this gelator, as well as its hydrogel was found to be toxic, which is why 
this material could not be used for drug delivery studies. 
 
The second half, chapter C of this thesis describes the synthesis of different ionene 
polymers as well as various applications. 
 
Fig. 51 A) General structures of ionene polymers and B) charged diammonium moieties with different 
structures and chain length. 
In chapter C1 the antimicrobial and hemolytic activity of ionenes (Fig. 51) was 
investigated. The majority of the polymers showed antimicrobial activity against the 
Gram-negative bacterium Escherichia coli, with minimum inhibition concentration 
values affected by both the topology of the polymer and the nature of the diamine 
linker. Most polymers revealed to be harmless towards red blood cells and therefor 
show a low hemolytic activity. In general, DABCO containing polymers exhibited the 
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lowest antimicrobial and the highest hemolytic activities. In contrast, meta-ionenes 
showed the best antimicrobial and lowest hemolytic activity, which makes them 
promising candidates for potential antimicrobial applications. 
 
In chapter C2 cationic vesicles derived from ionene polymers with alternating 
α,ω-tertiary diamine linker (ortho-DABCO, -C2 and -C6, see Fig. 51) and the non-ionic 
surfactant polysorbate 80 are presented. These vesicles were used in different 
formulations for the transfection of oligonucleotide single strands which are comple-
mentary to Renilla luciferase mRNA. Formulations based on ortho-DABCO and -C2 
were found to be non-toxic but those with ortho-C6 showed critical cell viabilities at 
higher ionene concentrations. When testing the efficiencies of the cationic vesicles to 
silence the activity of Renilla luciferase, those formulations with DABCO-ionene 
showed no efficacy. On the contrast, C2- and C6-ionene derived formulations (at non-
toxic ionene concentrations) could reduce the luciferase activity by 48 and 38%, 
respectively. The use of these formulations might be an interesting alternative to 
current transfection agents.  
 
Last but not least in chapter C3 ionenes with DABCO-linker were found to be 
able to gel water and acidic solutions. Here the topology, the substitution pattern 
(ortho-, meta- or para-) at the central benzene of the ionenes, was found to play an 
highly important role for the gelation properties. Ortho-DABCO showed superior 
gelation ability compared to the analogues meta-DABCO and para-DABCO in 
solutions of different pH and ionic strengths. Atomistic MD simulations have allowed 
to conclude that the distinctive properties of ortho-DABCO are due to the formation of 
specific polymer ··· polymer interactions (i.e. hydrogen bonds, N–H ··· π and intra-
molecular π – π stacking), which are facilitated by the binder effect of Cl- counterions. 
Polymer ··· polymer interactions are more abundant in ortho-DABCO than in meta-
DABCO and para-DABCO which is responsible for the superior gelation of ortho-
DABCO. 
 
 
In the annex, projects which are still under investigation are presented. 
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F   Annexes 
In this section, projects are presented which unfortunately did not deliver the desired 
results but still have the potential for other future applications.  
1. Amidine-Glu 
1.1 Aim 
With the aim to create another gelator by isosteric replacement one further derivative 
of N-stearoyl-L-glutamic acid C18-Glu was attempted to be synthesized. In this case 
we replaced the amide by an amidine function (amidine-Glu). 
 
1.2 Results 
Amidine-Glu was synthesized via a two-step reaction. Briefly, first an ice-cold 
solution of stearonitrile and EtOH in Et2O was treated with a flow of in-situ generated 
HCl gas. The resulting precipitate and L-glutamic acid were dissolved in DMSO, 
heated mildly to obtain a clear solution which was then stirred for 4 days at room 
temperature. Both steps achieved only quite poor yields and reproduction was not 
trivial. Nevertheless preliminary gelation experiments were be performed. According 
to the gelation behaviour of its predecessors C18-, click- and sulfo-Glu, organic 
solvents were tested first. However, amidine-Glu did not show gelation ability in 
most of the tested organic solvents including polar protic MeOH, polar non-protic like 
MeCN or unpolar solvents like DCM or silicon oil (Table 5A). The only organic 
solvent that led to a stable gel with amidine-Glu was DMSO. Probably the ionic 
structure of amidine-Glu hinders a gel-formation in the majority of organic solvents. In 
contrast to this, several 1 M solutions of strong acids (HCl, HBr, HI, H2SO4, H3PO4 
and HNO3) could be gelled relatively well, whereas weak organic acids like acidic 
acid and formic acid failed to form gels. Additionally a 0.1 M NaOH solution could be 
gelled. This indicates, that the pH must be extreme to ensure a high enough 
ionisation state (either protonation of amine or deprotonation of carboxyl function) to 
ensure sufficient solubility in an aqueous solution.  
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Table 5 Gelation ability of amidine-Glu in several organic solvents and aqueous solutions. B) Influence of 
acid concentration on gelation ability. 
A Solvent 
optical CGC Gel-
time 
Tgel 
B 
acidic CGC 
appearance (g L-1) (min) (ºC) solution (g L-1) 
 
EtOAc I - - - 
 
0.01 M HCl 33.3 
 
MeOH I - - - 
 
0.1 M HCl 25 
 
DCM I - - - 
 
1 M HCl 33 ± 24 
 
MeCN I - - - 
 
2 M HCl 25 
 
acetone I - - - 
 
0.1 M H2SO4 50 
 
silicon oil I - - - 
 
1 M H2SO4 10 ± 3 
 
DMSO yellow TG 37.3 n.m. n.m. 
 
2 M H2SO4 13 ± 2 
 
HCl white OG 33 ± 24 535 41 
   
 
H2SO4 white OG 10 ± 3 5,5 30 
   
 
HNO3 white PG 75 ± 35 3 n.m. 
   
 
H3PO4 white OG 16 ± 5 7 41 
   
 
HBr white PG 32 ± 25 5 n.m. 
   
 
HI red OG 25 - - 
   
 
CH3COOH I - - - 
   
 
HCOOH I - - - 
   
 
NaOH white OG 50 2 n.m. 
   
TG = transparent gel; OG = opaque gel; PG = partial gel; I = insoluble; n.m. not measured. Values with 
error were measured twice. Acidic solutions in table A are at a concentration of 1 M, NaOH is 0.1 M. 
In order to investigate the influence of acid concentration on the critical gelation 
concentration, the gelation of HCl and H2SO4 solutions at 4 and 3 different 
concentrations, respectively were tested (Table 5B). The gelation of HCl did not 
show any significant changes depending on acid concentration. In the contrast, with 
rising H2SO4 concentration from 0.1 to 1 M the CGC decreased around 5 fold. A 
further increase to 2 M H2SO4 concentration did not show relevant changes. However 
these are only preliminary results so for a clear conclusion further replications of 
these experiments would be necessary. 
1.3 Experimental Part 
Synthesis of ethyl stearimidate hydrochloride 
 
A solution of stearonitrile (5.0 g, 18.8 mmol) and EtOH abs. (1.13 mL, 19.3 mmol) in 
Et2O (25 mL) was cooled to 0 °C in an ice bath. Through this solution a thin stream of 
in-situ generated HCl gas was led for 5 h and subsequently the mixture was stirred 
for 1 further hour and then stored at 4 °C overnight. The formed precipitate was 
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filtered off and washed with ice cold Et2O (3 x 30 mL) to yield the desired product as 
white solid. 
Yield: 1.86 g (28%); C20H41NO·HCl (347.96) 
1H NMR (300 MHz, DMSO-d6) δ (ppm) = 7.32 - 6.98 (m, 2 H), 4.87 (dd, 1H), 4.03 
(dd, 1H), 2.56 (t, 1H), 2.26 (t, 1H), 1.59 – 1.50 (m, 2H), 1.35 (t, 2H), 1.23 (ps, 28H), 
1.16 (t, 2H), 0.85 (t, 3H). 
 
Synthesis of (1-iminooctadecyl)-L-glutamic acid hydrochloride amidine Glu 
 
Ethyl stearimidate hydrochloride (1.0 g, 2.87 mmol) and L-glutamic acid (634 mg, 
4.31 mmol) were dissolved in DMSO (50 mL) by gentle heating. The solution was 
stirred at room temperature for 4 days when 200 mL of EtOAc were added. The 
organic layer was washed with water/bringe 1:1 (3 x 200 mL) and dried over Na2SO4. 
Solvent was evaporated under reduced pressure to give the title compound as white 
solid. 
Yield: 0.24 g (19%); C23H44N2O4·HCl (448.79) 
1H NMR (300 MHz, DMSO-d6) δ (ppm) = 9.11 – 8.76 (m, 2H), 3.88 (ps, 1H), 2.45 – 
2.34 (m, 2H), 2.30 – 2.19 (m, 2H), 1.95 – 1.81 (m, 2H), 1.61 – 1.48 (m, 2H), 1.23 (ps, 
28H), 0.85 (t, 3H). 
MS (ESI): m/z (%) 413.34 (100) [M+H]+, calc. 413.34  
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2. X-bi(phenylalanine-diglycol)-benzene  
2.1 Aim 
The influence of topology on gelation abilities of ionenes was described in our group 
before,153,171,215 as well as in this thesis (chapter C3). But we wanted to test if the 
concept of topology can be transferred to low molecular weight gelators (LMWG), 
too. Two LMWG described by Feng et para-bi(phenylalanine-diglycol)-benzene (p-
PDB) bis(2-(2-hydroxyethoxy)ethyl) 2,2'-(terephthaloylbis (azanediyl))(2S,2'S)-bis(3-
phenylpropanoate) and its precursor (2S,2'S)-2,2'-(terephthaloylbis(azanediyl)) bis(3-
phenylpropanoic acid), which are able to gel water, were chosen as models. 
 
2.2 Results 
The synthesis of PDBs comprised of three steps. First x-phtaloyl chloride was 
reacted with L-phenylalanine methyl ester hydrochloride in the presence of NEt3 
which afforded good to moderate yields. Next step was the deprotection of the amino 
acids which was quantitative for the para-compound but resulted moderate (75%) 
and poor yields (36%) for meta- and ortho-compounds, respectively. Also the last 
step which was the esterification with two equivalents of diethylene glycol afforded 
quite poor yields (33%, 40% and 28% for para-, meta- and ortho-, respectively). 
Gelation could be achieved with p-PDB and its direct precursor p-precursor 1, 
however m-PDB, o-PDB and o-precursor 1 were not able to gel water. The direct 
precursor of m-PDB (m-precursor 1) could form at least a partial hydrogel at a CGC 
of 29 g L-1. 
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2.3 Experimental Part 
Synthesis of dimethyl 2,2'-(terephthaloylbis(azanediyl))(2S,2'S)-bis(3-phenyl-
propanoate) p-precursor 2 
 
A solution of terephtaloyl chloride (2.6 g, 12.8 mmol) in dry DCM (20 mL) was added 
dropwise to an ice cold solution of L-phenylalanine methyl ester hydrochloride (6.0 g, 
27.8 mmol) and NEt3 (8.0 mL, 115 mmol) in dry DCM (100 mL). The mixture was 
stirred at room temperature for 19 h. Solvent was evaporated and the residue was 
washed with EtOAc (3 x 50 mL) to afford the product as a white solid. 
Yield: 5.49 g (88%), C28H28N2O6 (488.54)  
1H-NMR (300 MHz. DMSO-d6) δ (ppm) = 9.00 (pd, 2H), 7.86 (s, 4H), 7.32 – 7.24 (m, 
8H), 7.22 – 7.19 (m, 2H), 4.72 – 4.64 (m, 2H), 3.64 (s, 6H), 3.22 – 3.06 (m, 4H). 
 
Synthesis of dimethyl 2,2'-(isophthaloylbis(azanediyl))(2S,2'S)-bis(3-phenyl-
propanoate) m-precursor 2 
 
A solution of isophtaloyl chloride (2.6 g, 12.8 mmol) in dry DCM (20 mL) was added 
dropwise to an ice cold solution of L-phenylalanine methyl ester hydrochloride (6.0 g, 
27.8 mmol) and NEt3 (8.0 mL, 115 mmol) in dry DCM (100 mL). The mixture was 
stirred at room temperature for 24 h. Solvent was evaporated under reduced 
pressure and to afford the crude product as a white solid which was used for the next 
step without further purification. 
Yield: 4.55 g (73%), C28H28N2O6 (488.54)  
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1H-NMR (300 MHz. DMSO-d6) δ (ppm) = 9.00 (pd, 2H), 7.86 (s, 4H), 7.32 – 7.24 (m, 
8H), 7.22 – 7.19 (m, 2H), 4.72 – 4.64 (m, 2H), 3.64 (s, 6H), 3.22 – 3.06 (m, 4H). 
 
Synthesis of dimethyl 2,2'-(phthaloylbis(azanediyl))(2S,2'S)-bis(3-phenylpropanoate) 
o-precursor 2 
 
A solution of phtaloyl chloride (2.6 g, 12.8 mmol) in dry DCM (20 mL) was added 
dropwise to an ice cold solution of L-phenylalanine methyl ester hydrochloride (6.0 g, 
27.8 mmol) and NEt3 (8.0 mL, 115 mmol) in dry DCM (100 mL). The mixture was 
stirred at room temperature for 24 h. Solvent was evaporated under reduced 
pressure and to afford the crude product as a white solid which was used for the next 
step without further purification. 
Yield: 4.55 g (73%), C28H28N2O6 (488.54)  
1H-NMR (300 MHz. DMSO-d6) δ (ppm) = 9.00 (pd, 2H), 7.86 (s, 4H), 7.32 – 7.24 (m, 
8H), 7.22 – 7.19 (m, 2H), 4.72 – 4.64 (m, 2H), 3.64 (s, 6H), 3.22 – 3.06 (m, 4H). 
 
Synthesis of (2S,2'S)-2,2'-(isophthaloylbis(azanediyl))bis(3-phenylpropanoic acid) p-
precursor 1 
 
p-precursor 2 (3.0 g, 6.1 mmol) was suspended in MeOH (20 mL) and cooled to 
0 °C when a solution of NaOH (2 M, 10 mL) was added. The mixture was stirred at 
room temperature for 18 h when TLC showed full conversion of the starting material. 
The mixture was then acidified with 3M HCl and the resulting white precipitate was 
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filtered off and washed until the washing water was almost neutral. The product was 
dried by lyophilization to afford the product as white powder. 
Yield: 2.92 g (103%) C26H24N2O6 (460.49) 
1H-NMR (300 MHz. DMSO-d6) δ (ppm) = 8.76 – 8.71 (m, 2H), 7.85 (s, 1H), 7.50 – 
7.47 (m, 2H), 7.39 – 7.35 (m, 2H), 7.32 – 7.14 (m, 12H), 4.61 – 4.56 (m, 2H), 3.60 (s, 
6H), 3.11 – 2.96 (m, 4H). 
 
Synthesis of (2S,2'S)-2,2'-(isophthaloylbis(azanediyl))bis(3-phenylpropanoic acid)  
m-precursor 1    
 
m-precursor 2 (4.0 g, 8.2 mmol) was suspended in MeOH (26 mL) and cooled to 
0 °C when a solution of NaOH (2 M, 14 mL) was added. The mixture was stirred at 
room temperature for 18 h when TLC showed full conversion of the starting material. 
The mixture was then acidified with 3M HCl and the resulting white precipitate was 
filtered off and washed until the washing water was almost neutral. The product was 
dried by lyophilization to afford the product as white powder. 
Yield: 2.81 g (75%) C26H24N2O6 (460.49) 
1H-NMR (300 MHz. DMSO-d6) δ (ppm) = 8.74 (pd, 2H), 8.18 (s, 1H), 7.88 (dd, 2H), 
7.52 (t, 2H), 7.30.-7.13 (m 9H) 4.62 – 4.53 (m, 2H), 3.64 (s, 6H), 3.22 – 3.02 (m, 4H). 
 
Synthesis of (2S,2'S)-2,2'-(phthaloylbis(azanediyl))bis(3-phenylpropanoic acid) 
o-precursor 1   
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o-precursor 2  (3.0 g, 6.1 mmol) was suspended in MeOH (20 mL) and cooled to 
0 °C when a solution of NaOH (2 M, 10 mL) was added. The mixture was stirred at 
room temperature for 19 h when TLC showed full conversion of the starting material. 
The mixture was then acidified with 3M HCl and the resulting white precipitate was 
filtered off and washed until the washing water was almost neutral. The product was 
dried by lyophilization to afford the product as white powder. 
Yield: 1.03 g (36%) C26H24N2O6 (460.49) 
1H-NMR (300 MHz. DMSO-d6) δ (ppm) = 8.59 – 8.52 (m, 2H), 7.51 – 7.45 (m, 2H), 
7.39 – 7.35 (m, 2H), 7.29 – 7.18 (m, 10H), 4.57 – 4.48 (m, 2H), 3.16 – 2.92 (m, 4H). 
 
Synthesis of bis(2-(2-hydroxyethoxy)ethyl) 2,2'-(terephthaloylbis(azanediyl))(2S,2'S)-
bis(3-phenylpropanoate) p-PDB 
 
p-precursor 1 (2.8 g, 6.1 mmol) and conc. HCl (4 drops) were dissolved in 
diethylene glycol (80 mL, 843 mmol) and stirred at 145 °C for 3.5 h. The clear brown 
solution was poured on 350 mL ice water. The gel like precipitate was filtered off, 
dried by lyophilization and remaining diethylene glycol was removed by washing with 
water. The dried crude was purified by column chromatography (DCM:MeOH 10:1 to 
5:1 (0.5% TFA)) to afford the title compound as brown solid. 
Yield 0.92 g (33%), C34H40N2O10 (636.70) 
1H-NMR (300 MHz. DMSO-d6) δ (ppm) = 9.01 – 8.84 (dd, 2H), 7.84 (s, 4H), 7.323– 
7.24 (m, 8H), 7.22 – 7.17 (m, 2H), 4.71 – 4.60 (m, 2H), 4.25 -4.12 (m, 3H) 3.63 – 
3.36 (m, 16H), 3.23 – 3.02 (m, 4H). 
MS (ESI): m/z (%) 637.28 (100) [M+H]+, 1273.5 (19) [2M+H]+, calc. 637.28 
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Synthesis of bis(2-(2-hydroxyethoxy)ethyl) 2,2'-(isophthaloylbis(azanediyl))(2S,2'S)-
bis(3-phenylpropanoate) m-PDB  
 
m-precursor 1 (1.0 g, 2.2 mmol) and conc. HCl (2 drops) were dissolved in 
diethylene glycol (80 mL, 843 mmol) and stirred at 145 °C for 3.5 h. EtOAc (150 mL) 
were added and diethylene glycol was removed by washing with water (3 x 150 mL). 
Remaining product in the collected aqueous layer was extracted with EtOAc 
(2 x 150 mL). Organic layer was dried over Na2SO4 and solvent was evaporated 
under reduced pressure. The crude product was purified by column chromatography 
(DCM:MeOH 10:1) to afford the title compound as brown solid. 
Yield 0.40 g (40%), C34H40N2O10 (636.70) 
1H-NMR (300 MHz. DMSO-d6) δ (ppm) = 9.02 (d, 2H), 8.23 (s, 1H), 7.93 (dd, 2H), 
7.56 (t, 1H), 7.32– 7.19 (m, 10H), 4.71 – 4.61 (m, 4H), 4.24 -4.12 (m, 4H) 3.62 – 3.51 
(m, 4H), 3.48 – 3.42 (m 6H), 3.21 – 3.07 (m, 4H). 
MS (ESI): m/z (%) 637.28 (100) [M+H]+, 1295.5 (14) [2M+Na]+, calc. 637.28 
 
Synthesis of bis(2-(2-hydroxyethoxy)ethyl) 2,2'-(phthaloylbis(azanediyl))(2S,2'S)-bis 
(3-phenylpropanoate) o-PDB 
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o-precursor 1 (0.5 g, 1.1 mmol) and conc. HCl (1 drops) were dissolved in 
diethylene glycol (15 mL, 152 mmol) and stirred at 65 °C for 3 h. EtOAc (75 mL) were 
added and diethylene glycol was removed by washing with water (3 x 75 mL). 
Remaining product in the collected aqueous layer was extracted with EtOAc (3 x 
75 mL). Organic layer was dried over Na2SO4 and solvent was evaporated under 
reduced pressure. The crude product was purified by column chromatography 
(DCM:MeOH 10:1) to afford the title compound as brown viscous oil. 
Yield 0.14 g (28%), C34H40N2O10 (636.70) 
1H-NMR (300 MHz. DMSO-d6) δ (ppm) = 8.76 – 8.84 (dd, 2H), 7.54 – 7.47 (m, 2H), 
7.42 – 7.39 (m, 2H), 7.32– 7.19 (m, 10H), 4.65 – 4.55 (m, 4H), 4.20 -4.08 (m, 4H) 
3.60 – 3.52 (m, 4H), 3.50 – 3.41 (m, 6H), 3.11 – 2.98 (m, 4H). 
MS (ESI): m/z (%) 637.28 (100) [M+H]+, 659.5 (66) [M+Na]+, calc. 637.28 
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3. New Ionenes 
3.1 Aim 
The influence of topology on gelation abilities of ionene polymers was described in 
our group before,153,171,215 as well as in this thesis (chapter C3). Therefor we wanted 
to test other ionene polymers for their potential enhancement of gelation by change 
of the topology. Two ionenes described by Yoshida et al (trans-cyclohexane-1,4-diyl) 
dibenzamide linked to  N,N,Nˈ,Nˈ-tetramethylhexane-1,6-diamine (p-cyclohex) and 
poly[pyridinium-1,4-diyliminocarbonyl-1,4-phenylene-methylene chloride] p-polypyr 
were chosen as models.216,217  
3.2 Results 
Synthesis of cyclohex ionenes was performed in two steps. Briefly, first step involves 
the amidation of trans-cylcohexanediamines with 4-(chloromethyl)benzoyl chloride in 
the presence of Et3N in DCM, followed by step-growth copolymerization of the 
obtained bis-benzamides with the desired α,ω-diamine linker under equimolar 
conditions in DMF at 80 ºC affording the desired polymers in good yields (80 and 
96%). Synthesis of m-cyclohex was not performed as trans-1,3-cyclohexanediamine 
is too expensive. Polypyr ionenes were synthesized via copolymerization of 
aminopyridines again with 4-chloromethylbenzoylchloride affording moderate yields 
(77 and 73%). Synthesis of o-polypyr failed. The four obtained ionenes were 
investigated towards their hydrogelation behaviour (Table 6). Unfortunately, 
o-cyclohex was not able to form hydrogels in contrast to the already described 
p-cyclohex. M-polypyr was able to gel water, however the literature known para-
topomer showed a lower and therefore better CGC.  
 
Table 6 Critical gelation concentration of ionenes in water. 
Gelator CGC (g L-1) 
m-polypyr 40 
p-polypyr 80 
o-cyclohex solution 
p-cyclohex 40 
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3.3 Experimental Part 
Synthesis of N,N'-((trans)-cyclohexane-1,2-diyl)bis(4-(chloromethyl)benzamide)    
o-cyclohex monomer 
  
To a stirred solution of trans-1,4-cyclohexanediamine (2.0 g, 17.5 mmol) and NEt3 
(4.87 mL, 35 mmol) in distilled DCM (150 mL) was added dropwise a solution of 
4-chloromethylbenzoylchlorid (6.65 g, 35 mmol) in distilled DCM (60 mL). The 
mixture was stirred at room temperature overnight. The precipitate was filtered off 
and then washed three times with DCM to obtain the product as a white powder 
Yield: 5.88 g (80%), C22H24Cl2N2O2 (419.35) 
1H-NMR (300 MHz, DMSO-d6) δ (ppm) = 8.32 – 8.34 (d, 2H), 7.82 – 7.85 (d, 4H), 
7.49 – 7.52 (d, 4H), 4.80 (s, 4H), 3.78 (s, 2H), 1.90 (m, 4H), 1.45 (m, 4H) 
 
Synthesis of N,N'-((trans)-cyclohexane-1,4-diyl)bis(4-(chloromethyl)benzamide)  
p-cyclohex monomer 
  
To a stirred solution of trans-1,2-cyclohexanediamine (2.0 g, 17.5 mmol) and NEt3 
(4.87 mL, 35 mmol) in distilled DCM (150 mL) was added dropwise a solution of 
4-chloromethylbenzoylchlorid (6.65 g, 35 mmol) in distilled DCM (60 mL). The 
mixture was stirred at room temperature for 24 h. The precipitate was filtered off and 
then washed with DCM to obtain a white powder 
Yield: 5.37 g (73%), C22H24Cl2N2O2 (419.35) 
1H-NMR (300 MHz, DMSO-d6) δ (ppm) = 8.31 – 8.28 (d, 2H), 7.68 – 7.70 (d, 4H), 
7.43 – 7.45 (d, 4H), 4.75 (s, 4H), 3.92 (s, 2H), 1.72 – 1.85 (m, 4H), 1.28 – 1.52 
(m, 4H). 
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Synthesis of poly[(dimethylaminio)hexane-1,6-diyl(dimethyliminio)methylene-1,4-
phenylenecarbonyliminio-trans-cyclohexane-1,2-diyliminocarbonyl-1,4-phenylene-
methylene dichloride] o-cyclohex 
 
To a stirred suspension of o-cyclohex monomer (5.88 g, 14 mmol) in DMF (470 mL) 
at 80 °C was added dropwise a solution of N,N,Nˈ,Nˈ-tetramethylhexane-1,6-diamine 
(2.42 g, 14 mmol) in DMF (95 mL). The mixture was stirred for 48 h. The precipitates 
were filtered off and washed two times with each DMF and acetone. Then it was 
dried under vacuum to obtain the product as a white powder. 
Yield 8.0 g (96%) 
1H-NMR (300 MHz, D2O) δ (ppm) = 7.82 – 7.88 (d, 4H), 7.60 – 7.62 (d, 4H), 4.50 
(s, 4H), 3.83 (s, 2H), 3.30 (s, 4H), 3.00 (s, 12H), 1.87 – 2.03 (m, 8H), 1.40 – 1.51 
(m, 8H) 
Synthesis of poly[(dimethylaminio)hexane-1,6-diyl(dimethyliminio)methylene-1,4-
phenylenecarbonyliminio-trans-cyclohexane-1,4-diyliminocarbonyl-1,4-phenylene-
methylene dichloride] p-cyclohex 
  
To a stirred suspension of o-cyclohex monomer (5.37 g, 12.8 mmol) in DMF 
(430 mL) at 80 °C was added dropwise a solution of N,N,Nˈ,Nˈ-tetramethylhexane-
1,6-diamine (2.12 g, 12.8 mmol) in DMF (85 mL). The mixture was stirred for 48 h. 
The mixture was cooled in the freezer and small crystals were dried under vacuum.  
Yield: 1.5 g (20%)  
1H-NMR (300 MHz, D2O) δ (ppm) = 7.56 – 7.59 (d, 4H), 7.43 – 7.47 (m, 4H), 4.36 
(s, 4H), 3.88 (s, 2H), 3.15 (s, 4H), 2.87 (s, 12H), 1.72 – 1.90 (m, 8H), 1.28 – 1.43 
(m, 8H). 
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Synthesis of poly[pyridinium-1,2-diyliminocarbonyl-1,4-phenylene-methylene chloride] 
o-polypyr 
 
To a suspension of 3-aminopyridine (2.0 g, 21.2 mmol) in DCM (34 mL) and Et3N 
(3.3 mL, 23.63 mmol) a solution of 4-chloromethylbenzoylchloride (4.02 g, 
21.2 mmol) in DCM (16 mL) was added dropwise over 30 minutes. The reaction 
mixture was refluxed overnight at 50 °C, until TLC analysis showed full conversion of 
the starting materials. The mixture was cooled down to RT, filtered, washed with cold 
DCM (seven times), dried in vacuum. The product was obtained as light yellow 
powder. 
Yield: 4.65g (77%), C13H11N2OCl 
1H NMR (300 MHz, D2O) δ (ppm) = 9.32 (s, 1 H), 8.58 (m, 1H), 8.31 (m, 1H), 7.62 – 
7.90 (m, 1H, 2H), 7.50 (s, 2H), 5.70 (s, 2H).  
 
Synthesis of poly[pyridinium-1,4-diyliminocarbonyl-1,4-phenylene-methylene chloride] 
p-polypyr 
 
To a suspension of 4-aminopyridine (2.0 g, 21.2 mmol) in DCM (34 mL) and Et3N 
(3.3 mL, 23.63 mmol) a solution of 4-chloromethylbenzoylchloride (4.02 g, 
21.2 mmol) in DCM (16 mL) was added dropwise over 30 minutes. The reaction 
mixture was refluxed overnight at 50 °C, until TLC analysis showed full conversion of 
the starting materials. The mixture was cooled down to RT, filtered, washed with 
DCM (seven times) and methanol (two times), dried in vacuum. The product was 
obtained as white powder. 
Yield: 4.40g (73%), C13H11N2OCl 
1H NMR (300 MHz, D2O) δ (ppm) = 8.58 (d, 2 H), 8.18 (d, 2H), 7.88 (d, 2H), 7.46 
(d, 2H), 5.64 (s, 2H). 
NMR Spectra and PXRD 
108 
 
G   NMR Spectra and PXRD 
 
1H-NMR spectrum (300 MHz. DMSO-d6) of C18-Glu. 
 
1H-NMR spectrum (300 MHz. D2O) of 1H-imidazole-1-sulfonyl azide. 
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1H-NMR spectrum (300 MHz. DMSO-d6) of (S)-2-azidopentanedioic acid. 
 
1H-NMR spectrum (300 MHz. DMSO-d6) of click-Glu. 
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1H-NMR spectrum (300 MHz. DMSO-d6) of sulfo-Glu. 
 
1H-NMR spectrum (300 MHz. MeOD-d3) of methyl L-phenylalaninate. 
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1H-NMR spectrum (300 MHz. CDCl3-d3) of methyl acetyl-L-phenylalaninate. 
 
1H-NMR spectrum (300 MHz. MeOD-d3) of (S)-N-(1-hydrazineyl-1-oxo-3-phenylpropan-2-yl)acetamide. 
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1H-NMR spectrum (300 MHz. MeOD-d3) of FAG. 
 
1H-NMR spectrum (300 MHz. DMSO-d6) of ortho-monomer.
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1H-NMR spectrum (300 MHz. DMSO-d6) of meta-Precursor. 
 
1H-NMR spectrum (300 MHz. DMSO-d6) of para-Precursor. 
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1H-NMR spectrum (300 MHz. D2O) of o-DABCO. 
1H-
NMR spectrum (300 MHz. D2O) of o-C2. 
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1H-NMR spectrum (300 MHz. D2O) of o-C3. 
1H-
NMR spectrum (300 MHz. D2O) of o-C6. 
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1H-NMR spectrum (300 MHz. D2O) of m-DABCO. 
 
1H-NMR spectrum (300 MHz. DMSO-d6) of m-C2. 
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1H-NMR spectrum (300 MHz. DMSO-d6) of m-C3. 
 
1H-NMR spectrum (300 MHz. DMSO-d6) of m-C4. 
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1H-NMR spectrum (300 MHz. D2O) of m-C6. 
 
1H-NMR spectrum (300 MHz. D2O) of p-DABCO. 
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1H-NMR spectrum (300 MHz. D2O) of p-C2. 
 
1H-NMR spectrum (300 MHz. D2O) of p-C3. 
NMR Spectra and PXRD 
120 
 
 
1H-NMR spectrum (300 MHz. DMSO-d6) of p-C4. 
 
1H-NMR spectrum (300 MHz. DMSO-d6) of ethyl stearimidate. 
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1H-NMR spectrum (300 MHz. DMSO-d6) of amidin-Glu. 
 
1H-NMR spectrum (300 MHz. DMSO-d6) of p-precursor 2. 
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1H-NMR spectrum (300 MHz. DMSO-d6) of m-precursor 2. 
 
1H-NMR spectrum (300 MHz. DMSO-d6) of p-precursor 2. 
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1H-NMR spectrum (300 MHz. DMSO-d6) of p-precursor 1. 
 
1H-NMR spectrum (300 MHz. DMSO-d6) of m-precursor 1. 
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1H-NMR spectrum (300 MHz. DMSO-d6) of o-precursor 1. 
 
1H-NMR spectrum (300 MHz. DMSO-d6) of p-PDB. 
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1H-NMR spectrum (300 MHz. DMSO-d6) of m-PDB. 
 
1H-NMR spectrum (300 MHz. DMSO-d6) of o-PDB. 
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1H-NMR spectrum (300 MHz. D2O) of o-cyclohex-monomer. 
 
1H-NMR spectrum (300 MHz. D2O) of o-cyclohex. 
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1H-NMR spectrum (300 MHz. D2O) of p-cyclohex-monomer. 
 
1H-NMR spectrum (300 MHz. D2O) of p-cyclohex. 
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1H-NMR spectrum (300 MHz. D2O) of m-polypyr. 
 
1H-NMR spectrum (300 MHz. D2O) of p-polypyr. 
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PXRD of FAG powder. 
 
 
 
PXRD of a xerogel derived from FAG based hydrogel. 
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PXRD of a xerogel derived from FAG based gel in MeCN. 
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H   List of Abbreviations 
1D  one-dimensional 
3D  three-dimensional 
µ  micro 
brs  broad singlet 
calc.   calculated 
CAMP camptothecin 
CGC  critical gelation concentration 
DABCO 1,4-diazabicyclo[2.2.2]octane  
DCM  dichloromethane (methylene chloride) 
DLS  dynamic light scattering 
DMF  N,N-dimethylformamide 
DMSO dimethyl sulfoxide 
DNA  deoxyribonucleic acid 
DSC  differential scanning calorimetry 
EDTA  ethylenediaminetetraacetic acid 
Et2O  diethyl ether 
EtOAc ethyl acetate 
EtOH  ethanol 
EI  electron impact ionization 
ESI  electron spray ionization 
FESEM field emission scanning electron microscopy 
GA  glycyrrhizic acid 
h  hours 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HPLC  high pressure/performance liquid chromatography 
HRMS high resolution mass spectrometry 
i-PrOH iso-propanol 
LMWG low-molecular-weight gelator 
logP  partition coefficient 
m  milli 
M  mol/liter 
MeCN  acetonitrile 
MeOH methanol 
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MES  2-(N-morpholino)ethanesulfonic acid 
min  minutes 
MITOX mitoxantrone hydrate 
MS  mass spectrometry 
n  nano 
NEt3  triethylamine 
NMR  nuclear magnetic resonance 
OXY  oxytetracycline hydrochloride 
PBS  phosphate buffered saline 
PEE  poly(L-lysine) 
PEG  polyethylene glycol 
PEI  poly(ethylenimine) 
Ph  phenyl 
ppm  parts per million  
QAS  quaternary ammonium salt 
RNA  ribonucleic acid 
RT  room temperature 
s  singlet 
SAXS  small angle X-ray scattering 
Scr  scramble 
SEM  scanning electron microscopy 
t  triplet 
TBAF  tetra-n-butylammonium fluoride 
Tgel  melting temperature of a gel 
TGYE  tryptone glucose yeast extract 
THF  tetrahydrofuran 
TFA  trifluoroacetic acid 
UV-Vis ultraviolet–visible spectroscopy   
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